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Abstract 
Chronic sleep disturbances are associated with the development and progression of 
chronic conditions such as cardiovascular disease, hypertension, obesity and cancer. Sleep 
disturbances are categorized as exceptionally short or long sleep duration as well as difficulty 
falling asleep or difficulty maintaining sleep. The prevalence and incidence of type II diabetes 
increased three-fold among adults in the United States between 1980 and 2012. The goals of this 
research are to assess the bidirectional association between chronic sleep disturbances and 
diabetes among older adults, by gender, as well as the joint effects of diabetes and chronic sleep 
disturbances on healthy dietary consumption.  
Participants were selected from the Health and Retirement Study, a longitudinal, 
nationally representative sample of individuals over the age of 50 in the United States. 
Multivariate Cox-proportional hazard models were used to assess the association between 
chronic sleep disturbances and development of diabetes within eight years of follow up.  
Women who reported chronic sleep disturbances at baseline (2006) had a 27% greater 
hazard of developing diabetes within eight years than those without chronic sleep disturbances 
(OR 1.37; 95% CI 1.17-1.60). The association was attenuated after multivariable adjustment for 
time-varying covariates yet was still significant (OR 1.27; 95% CI 1.08-1.50). While the 
association was in the same direction in men, it was not statistically significant (adjusted for 
time-varying covariates OR 1.14; 95%CI 0.88-1.48). In assessing the relationship between newly 
 x 
identified cases of diabetes and the development of sleep disturbances, women with newly 
reported diabetes were 80% more likely to develop a chronic sleep disturbances after four years 
than those without diabetes (OR 1.80, 95% CI 1.01-3.20). However, the association was 
attenuated and no longer significant after multivariable adjustment (OR 1.63; 95% CI 0.86-3.12). 
While it does appear that men with newly reported diabetes have a slightly higher odds of 
developing chronic sleep disturbances, the results do not reach statistical significance 
(multivariable adjusted OR 1.14; 95%CI 0.69-1.90).  
In assessing the associations between the comorbidity of chronic sleep disturbances and 
diabetes on consumption of a healthy diet, defined as a Mediterranean diet, men with diabetes 
appear to consume a healthier diet unless they have a chronic sleep disturbance. Women with 
diabetes do not appear to consume a healthier diet and those with diabetes and chronic sleep 
disturbances are 20% less likely to consume a healthy diet than those without diabetes or chronic 
sleep disturbances. Sleep disturbances appear to have an antagonistic association with diabetes 
and adherence to a healthy diet in both women and men.  
In conclusion, our research shows that chronic sleep disturbances, specifically trouble 
falling asleep or staying asleep, are associated with the onset of diabetes in women, women with 
diabetes are somewhat more likely to develop chronic sleep disturbances within four years of 
receiving a diagnosis of diabetes, and that chronic sleep disturbances have a negative association 
with healthy dietary intake among those with diabetes. Additionally, our research shows that 
women report greater rates of sleep disturbances and the relationship between sleep disturbances 
and diabetes varies by gender as well as by race and ethnicity. Novel aspects of this research 
include the findings related to self-reported sleep quality, rather than sleep duration, as well as 
the quantification of differences by gender and race/ethnicity. In an increasingly aging, diverse 
 xi 
population, understanding the impact of sleep disturbances in the onset and progression of 
diabetes elucidates an important area for prevention as well as detection and treatment at the 
individual level as well as the population-level. 
 
 1 
Chapter 1 Introduction 
Background  
Diabetes mellitus is a chronic condition that takes a considerable toll at the individual and 
societal level. Diabetes is the most frequently diagnosed chronic condition and the chronic 
disease that is increasing at the most rapid rate in the world (1). Between 1980 and 2008, the 
U.S. population age 65 and older experienced the greatest increase in the prevalence of diabetes 
with an increase from 8% to nearly 20%, indicative of the global pandemic of diabetes (2). 
Between 2008 and 2012, the prevalence of diabetes plateaued in the U.S. with the exception of 
specific subgroups of the population that continued to experience an increase in incidence and 
prevalence. This included younger adults, those with a high school education or less, and 
Hispanic as well as non-Hispanic black adults (3-5). Differences in the prevalence of diabetes 
due to age and gender have been reported as well. In the United States, the prevalence of 
diabetes increases through age 74, with the greatest increases during older adulthood (ages 45-
74) after which the prevalence remains relatively stable (2). Diabetes is more prevalent in men 
than women, with the exception of women age 80 and over in which diabetes is slightly higher in 
women (1%), likely due to increased longevity in women and increased diabetes in this older age 
group. While age and gender are non-modifiable risk factors for the development of type II 
diabetes, modifiable lifestyle factors are largely responsible for the increase in type II diabetes 
(2). These lifestyle factors are primarily due to increased caloric consumption, characterized by 
simple carbohydrates and high sugar content, and decreased physical activity- an energy 
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imbalance- leading to obesity. However, these traditional lifestyle behaviors do not fully explain 
the increased incidence of type II diabetes, nor does family history or, genetics. 
Individuals with diabetes are likely to have multiple chronic conditions. Comorbidity 
with hypercholesteremia, hypertension, obesity, heart disease and stroke is not uncommon 
among those with diabetes. Chronic conditions can also be the result of diabetes including 
conditions such as kidney disease, blindness and neuropathy. Additionally, individuals with 
diabetes are more likely to develop physical and cognitive disabilities such as dementia (2). 
Thus, not only is diabetes itself a concern, but the high rate of associated comorbid conditions 
leads to greater concern, and greater cost. 
The costs associated with diagnosed diabetes are staggering. In 2008, it was estimated 
that one out of every five dollars spent on health care in the United States was spent on diabetic 
patients (6).  The total estimated cost of diagnosed diabetes was $174 billion in 2007. In 2012, it 
was estimated that the total annual cost of diagnosed diabetes had increased to $245 billion, a 
41% increase in five years.  Seventy-two percent (72%) of the $245 billion was attributable to 
direct medical costs and the remainder due to lost productivity. At the individual level, the total 
annual health care costs of those with diagnosed diabetes are close to $14,000, likely due to the 
increased risk of comorbid conditions in this population. Close to $8,000, or 58% of the annual 
medical costs incurred were attributable to the diagnosed diabetes, including doctor’s visits, 
medical tests and medication. These increased health care costs are likely to come at a time in 
life in which health care coverage is extremely expensive and prescription coverage is limited for 
a large portion of the affected population.  Two-thirds of these costs are covered by the 
government (Medicare, Medicaid, the military) and by uninsured individuals (3.2%). With the 
 3 
cost of insulin increasing three-fold in the last ten years, the undue burden on our aging 
population must be addressed (7).  
The daily goal of those with diabetes is to maintain glycemic levels within a healthy 
range in order to reduce the deleterious potential effects of this treatable, but incurable, chronic 
disease. Dietary intake, physical activity, obesity and medication all affect glycemic levels. As 
the population-based prevalence of diabetes and obesity have increased over the past thirty years, 
chronic sleep disturbances have increased as well (8). Sleep disturbances can lead to metabolic 
dysfunction/deregulation, poor glycemic control and reduced insulin sensitivity. Sufficient sleep 
quantity as well as sleep quality helps to achieve and maintain healthy glucose levels as well as 
decrease insulin resistance.  
Numerous cross-sectional studies have reported increased rates of sleep disruptions, 
including short sleep duration, among adults with diabetes compared to those without diabetes 
(9-17). Women tend to report greater levels of comorbidity of diabetes and chronic sleep 
disturbances than men. Several longitudinal studies have provided evidence that inadequate sleep 
duration or sleep disturbances are associated with the development of diabetes (18-20). Most of 
these studies have been conducted outsides of the U.S. and gender-based differences have not 
been reported.  
Little is known about the degree to which those who previously did not have sleep 
disturbances are likely to develop a chronic sleep disturbance after a recent diagnosis of diabetes. 
This is an important question to address as chronic sleep disturbances appear to increase the risk 
of poor glycemic control and insulin sensitivity (21). While it is plausible that there is an initial 
period of increased sleep disturbances related to the anxiety of a new diagnosis, and 
incorporating new behaviors and medications into one’s lifestyle, it is not known whether new 
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sleep disturbances continue well past the initial diagnostic and medication regulation phase. 
Sleep disturbances can lead to metabolic deregulation and decrease one’s likelihood to adhere to 
dietary restrictions (21). This dissertation will provide new information on whether chronic sleep 
disturbances modify the association between diabetes and dietary intake and lead to lower 
adherence to a healthy diet, assessed using a Mediterranean-style diet score. 
Sleep architecture 
Humans have a basic biologic need for sleep. Sleep is necessary for the maintenance of 
our physical and cognitive health (22). An increasing emphasis has been placed on the 
epidemiology of sleep in recent years to better understand the associations between sleep quality 
and duration and health (23-25). With sleep disturbances on the rise, and societal changes that 
seem to promote decreased sleep, knowledge of the associated risks is becoming increasingly 
important. 
Sleep architecture refers to the stages of sleep and the cycles that occur throughout the 
night. While the focus of this dissertation is on overall self-reported sleep quality, rather than 
disruptions in sleep stages, it is important to understand sleep architecture as it relates to the 
development of chronic conditions. Briefly, there are 4 stages of sleep that comprise a cycle and 
each cycle is approximately ninety (90) minutes in duration. The stages are: 
Light sleep - stages 1 and 2. Stage 1 is marked by drowsiness while still being conscious 
whereas in stage 2, you are just beginning to slip into sleep. During light sleep, you are easily 
awoken and will remember being awoken. Adults typically spend 40-60% of total sleep time in 
this stage.  
Deep sleep - stages 3 & 4. Stage 3 is marked by slowed breathing, slowed heart rate and 
lower body temperature. Stage 4 is considered deep sleep, or slow wave sleep (SWS). During 
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this stage, it is very difficult, if not impossible, to wake someone up. If awoken, the individual 
may not remember the awake episode the next day. Deep sleep is considered restorative and 
important for our health. Adults typically spend 12-18% of their time sleeping in this stage. 
Rapid Eye Movement (REM)-stage 5. Stage 5 is the dream stage as this is when dreams 
occur. During this stage, brain activity increases, heart rate increases and limbs are paralyzed. It 
is difficult, but not impossible, to be awoken during this stage.  REM occurs later at night and is 
associated with mood and memory. Adults typically spend 15-25% of their sleeping time in this 
stage. 
Awake. While this is not a stage of sleep, it is not uncommon to experience several 
episodes of brief periods of awakening throughout the night. Many of these episodes are not 
recollected the following day as they are so brief. Frequent wakening throughout the night is a 
primary symptom of sleep apnea. Poor sleep quality is marked by waking up after falling asleep 
and not being able to fall back asleep.  
Over the course of the night we typically cycle from light sleep to deep sleep, back to 
light sleep, and then to stage 5, REM. These cycles occur approximately 5-6 times per night with 
the duration of deep sleep typically increasing with each cycle. While it is important to cycle 
through each of the stages in the course of a night’s sleep, the amount of time spent in each stage 
varies and changes over time. As individuals age, less time in deep sleep is required and more 
time spent in light sleep or episodes of being awake occur. In general, we spend approximately 
one-third of our lives sleeping, although the required duration of sleep varies from one person to 
the next. Additionally, the amount of sleep required on a daily basis varies by individual and 
decreases with age (22, 26).  
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Sleep and metabolism 
Glucose regulation is affected by the sleep-wake cycle with increases in glucose levels 
found to occur during stages 2-4, or non-REM sleep, and declines in blood glucose levels during 
periods of being awake (21). During REM sleep, glucose levels remain stable. Thus, natural 
variation in glucose levels are observed over the course of a sleep cycle. Insulin levels follow a 
similar pattern to glucose levels. Studies of sleep disruption have found disturbances in glucose 
levels and insulin regulation to occur after sleep disruptions of just a few nights. Disruption to 
sleep cycles, specifically reductions in short wave sleep, can lead to disruptions in glucose levels 
thus potentially increasing the risk of glucose intolerance and incident diabetes over prolonged 
periods of disruption (27-29). 
Sleep disturbances have also been shown to impact the hormones that regulate appetite, 
such as leptin and gherlin, as well as stimulate an increased appetite for high carbohydrate foods. 
Several studies have shown disruptions in leptin and gherlin, two hormones that influence 
appetite, after sleep deprivation and sleep disturbances were controlled in experimental settings 
(30-33). Additionally, food cravings for high carbohydrate foods, such as sweet or salty snack 
foods and starchy foods, were increased after sleep deprivation. (34, 35). After these 
experimental conditions, caloric intake from regular meals stayed the same as during usual, 
uninterrupted sleep duration, but caloric intake from snacks increased by close to 500 kcal. If 
chronic sleep disturbances lead to chronic over-consumption of unhealthy foods, an increased 
risk of obesity will ensue. Additionally, Vgontzas et al found that reduced sleep over the course 
of one week resulted in increased inflammation, also risk factors for insulin resistance and 
diabetes (36). 
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Sleep and diabetes 
Recent studies have examined the association between chronic sleep disturbances and the 
development of type II diabetes. A systematic review by Cappuccio and colleagues (18) found 
that both sleep duration and sleep quality predict the risk of developing type II diabetes. The 
review included ten studies and found the greatest risk among those who reported difficulty 
initiating sleep (RR 1.57; 95% CI 1.25-1.97) and difficulty maintaining sleep (RR 1.84; 95% CI 
1.39-2.43). However, the review was unable to report differences in risk by gender or by 
race/ethnicity and sleep quality in women was only assessed in studies conducted outside of the 
U.S..  Meisinger and colleagues (10) found that difficulty maintaining sleep was associated with 
a higher risk of developing type II diabetes among adults age 25-74 with an average follow-up of 
7.5 years. The hazard ratio was greater in women than men (women HR 1.98; 95% CI 1.20-3.29; 
men HR 1.60; 95% CI 1.05-2.45). However, difficulty initiating sleep was not significantly 
associated with developing diabetes in men or women. The study population included 
participants from the MONICA study conducted in Germany, a racially and ethnically 
homogenous population. Hoevenaar-Blom and colleagues (37) found that short sleep duration 
accompanied by sleep disturbances increased the risk of incident cardiovascular disease after 10-
15 years of follow up. However, this study was a population-based study in the Netherlands and 
was unable to detect or report differences by gender or race/ethnicity.  
Disparities in sleep duration and sleep quality have been identified for women, compared 
to men, and among Black adults compared to white and Hispanic adults (12, 14, 38-46). 
Numerous studies, primarily cross-sectional, have examined the association between sleep 
duration, and to a lesser degree sleep quality, and incident diabetes in adult populations (9-20, 
47, 48). Yet, a gap exists in the current literature in the role of poor sleep quality and diabetes 
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among a nationally representative, longitudinal, sample of multi-ethnic older women and men. 
Most studies to date are of populations of European or Asian descent and few have sufficient 
sample sizes of Black or Hispanic populations to report associations among these subgroups. 
Given the higher rates of sleep disturbances reported by Black adults and the higher rates of 
obesity, hypertension and type II diabetes among Black and Hispanic adults, understanding the 
role of sleep disturbances in the development of diabetes could provide information that has both 
clinical relevance as well as important public health implications. Given the aging population, 
shifting demographics and the increase in type II diabetes in the United States, there is a need to 
examine these associations differentially by gender as well as by race/ethnicity within gender. 
Numerous studies have reported increased rates of sleep disturbances among Black and Hispanic 
adults in the U.S. population. Many of these focus on psychosocial stressors and socio-economic 
conditions associated with sleep disturbances. The Multi-Ethnic Study of Atherosclerosis 
(MESA) included 2230 participants with an average age of 68.8 years (39).  Multiple measures 
of sleep quality were used including polysomnography, actigraphy and a self-reported 
questionnaire.  Chen and colleagues found that Black participants had higher rates of sleep 
apnea, short sleep, poor sleep quality and daytime sleepiness than whites. Hispanic participants 
had higher odds of sleep apnea and short sleep. Black men and Hispanic women were more 
likely to report poor sleep quality. The odds of poor sleep quality decreased with age in Blacks 
but increased among Hispanics. While this study concludes that Blacks and Hispanics may be at 
an increased risk for the development of chronic conditions related to poor sleep, the association 
between chronic conditions and sleep disturbances was not assessed in this cross-sectional study.  
To our knowledge, no studies have assessed the development of chronic sleep 
disturbances after the diagnosis of type II diabetes using longitudinal data. The development of 
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new sleep disturbances is important to assess as poor quality sleep could lead to higher glycemic 
levels. Several cross-sectional observational studies have found higher hemoglobin A1C 
(HbA1c) levels, a measure of glycemic control, among those with diabetes who also report short 
sleep or sleep disturbances (11, 45, 47).  
Sleep and dietary intake; Mediterranean diet 
The Mediterranean diet has been identified as a plant-based dietary pattern that is 
associated with healthy aging, improved glycemic control and reduced insulin resistance in 
healthy populations, as well as in those with cardiovascular disease including hypertension and 
diabetes (49,50). Plant-based diets that are naturally high in polyphenols and low in saturated fats 
are also associated with decreased inflammation (51-54). Recent evidence also supports the role 
of the Mediterranean Diet in improving the gut microbiome thereby reducing inflammation and 
potentially improving glycemic control as well (55,56). The Mediterranean diet is considered a 
healthy diet for those with diabetes and meets the key dietary criteria outlined by the American 
Diabetes Association as it is naturally low in saturated fats, highly processed foods and refined 
carbohydrates.  
In 2003, Trichopoulou and colleagues developed a score based on previous studies of the 
qualities and benefits of a Mediterranean diet (57-60). During this time, Willett and colleagues 
described a new food pyramid based on the Mediterranean diet (59). The development of food 
scores allowed for the focus on intake of individual food items, such as olive oil or fish, as well 
as an overall healthy dietary pattern. Dietary patterns of multiple food components may provide 
more information regarding the antagonistic and synergistic effects of consuming a variety of 
foods. The score developed by Trichopoulou and colleagues is useful in assessing the degree of 
consumption of Mediterranean diet. Ten components of the diet were identified: cereals, 
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potatoes, fruits and nuts, vegetables, legumes, fish, meat, dairy products, olive oil, potatoes and 
eggs. Each of the ten components were assigned a score ranging from 0 to 1 based on gender-
specific median values. A score could then be calculated for individuals ranging from 0 to 9 with 
0 representing no consumption of a Mediterranean diet and 9 representing the highest level of 
consumption across all eleven categories of the Mediterranean diet. The score was later revised 
to include nine components. Potatoes, poultry and dairy products were removed from the score, 
nuts were added as a separate component, and olive oil was replaced by a ratio of 
monounsaturated to saturated fats. The replacement of olive oil consumption with a ratio of 
monounsaturated fats to saturated fats score facilitates the translation of this component to non- 
Mediterranean populations given the lower intake of olive oil. Additionally, moderate 
consumption of alcohol was added as a beneficial component. This score is referred to as the 
alternate Mediterranean diet (aMedDiet) and ranges from 0 to 9, with 9 being indicative of 
greater adherence to a Mediterranean-style diet. A score of one is given on any component for 
consumption above the median intake, with the exception of alcohol consumption and 
red/processed meat consumption. The indices are created separately for men and women given 
the variation in dietary intake and caloric intake by gender. Thus, median values are calculated 
separately for men and women and the score is calculated by gender. Samieri and colleagues 
assessed the relationship between the aMedDiet and healthy aging among participants of the 
Nurses’ Health Study (NHS) who were free of chronic conditions at baseline (61). They found 
that healthy agers, those who remained free of chronic conditions, were more likely to consume 
an aMedDiet in the highest quintile of consumption compared to usual agers. DeKoning and 
colleagues assessed the risk of developing diabetes among participants in the Health 
Professionals Follow Up Survey (HPFS) who consumed an aMedDiet in the highest quartile 
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compared to those in the lowest quartile (62). A lower risk of developing type 2 diabetes was 
found among those who consumed a healthier diet, such as the aMedDiet, than those who did 
not. While the aMedDiet has been studied among populations at risk of developing or those 
already diagnosed with a chronic condition, to our knowledge, the effect of comorbidity of 
chronic sleep disturbances and diabetes on consumption of a Mediterranean-style diet has not 
been assessed (63-66). 
Conceptual Framework and Specific Aims 
Conceptual framework 
The following diagram depicts the conceptual framework of the association between 
sleep disturbances and diabetes. Obesity is a primary confounder as it is associated with both the 
development of sleep disturbances as well as the development of diabetes. Obesity will be 
included as a confounder in each of the three aims. Unregulated glucose levels, reduced insulin 
sensitivity and increased inflammation are intermediate variables on the causal pathway in the 
development of diabetes. These variables were not assessed in the current study. Other 
demographic, socio-economic, health and psychosocial factors will be included as covariates in 
assessing the bi-directional relationships between chronic sleep disturbances and incident 
diabetes. Family history of diabetes is currently an unmeasured confounder in our studies. Future 
studies could include genetic information related to the increased risk of developing diabetes. 
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Figure 1.1 Conceptual framework of the bidirectional association of chronic sleep disturbances and type II diabetes. 
 
Single-headed arrows represent an association in one direction. Double-headed arrows represent an association in 
both directions. Gray arrows indicate unmeasured confounders, intermediate variables or outcomes that are not 
included in our statistical models (biochemical, diabetic complications/comorbidity and family history/genetics). 
Heavier blue arrows indicate the primary relationship of interest: the bidirectional association between chronic sleep 
disturbances and type II diabetes. Lighter blue arrows indicate relationships between covariates. 
Specific Aims 
This dissertation will characterize the bi-directional association of chronic sleep 
disturbances and newly reported type II diabetes among a national, multi-ethnic sample 
representative of adults aged 50 and older residing in the United States.  First, this study will 
utilize longitudinal data from the Health and Retirement Study (HRS) to examine the 
relationship between poor sleep quality and incident diabetes over an eight-year period from 
2006 to 2014 (67-70). Next, the association between newly reported type II diabetes and the 
development of chronic sleep disturbances over a four-year period will be assessed. Finally, this 
study will assess the association of poor sleep quality with dietary intake among adults with, and 
without, diabetes based on self-reported consumption of a Mediterranean-style diet (71-72). 
Differences by gender will be assessed for each of the three aims. 
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Aim 1. Determine the association between chronic sleep disturbances and incident type II 
diabetes.  
a) Are baseline sleep problems associated with incident type II diabetes over the coming 
eight years? 
b) Does this association vary by gender? 
 
Aim 2. Determine the association between newly reported diabetes and the development of 
chronic sleep disturbances. 
c) Are those with diabetes at higher risk of developing sleep problems within 4 years than 
those without diabetes? 
d) Does this association vary by gender? 
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Aim 3. Determine the association between comorbidity of chronic sleep disturbances and 
diabetes and the effect on healthy dietary intake, measured by a Mediterranean diet score. 
e) Are those with diabetes and chronic sleep disturbances less likely to consume a healthy 
diet, as measured by a Mediterranean Diet score, than those without sleep problems? 
f) Does this association vary by gender? 
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Public health significance and implications 
This dissertation will provide additional information on the risks associated with poor 
quality sleep. Given that sleep is a basic biological need, and poor quality sleep is a concern over 
the lifecourse, these findings will help to inform the public health discourse on the potentially 
deleterious effects of chronic sleep disturbances. In doing so, a focus on the necessity of quality 
sleep and ensuring that the conditions necessary for high quality sleep (i.e. sleep hygiene) can 
then be addressed. More specifically, the results of this dissertation will further our knowledge of 
the chronic sleep disturbances and the multi-directional association with type II diabetes. In 
doing so, this dissertation will provide additional evidence to support the role of sleep as a 
critical measure of health that should be assessed among those with, and those at risk of 
developing, type II diabetes. Doing so can potentially improve quality of life and decrease the 
costs and burden associated with the comorbidity of chronic conditions. 
Currently, the American Diabetes Association recommendations for those recently 
diagnosed with diabetes include guidance on dietary intake, physical activity, alcohol and 
smoking, weight loss, support and medication but not on the importance of maintaining sleep 
quality (73). Training among physicians on the importance of healthy sleep is rarely covered in 
medical school (74). However, given our increased knowledge of the deleterious effects of poor 
quality sleep and chronic sleep disturbances, prevention, detection and treatment should be 
emphasized.  
As we turn to new frontiers in health care, led by the move towards individualized 
medicine, the need to examine subgroups of populations is of greater importance. It is necessary 
to determine the subgroups of populations at increased risk for the development and progression 
of disease. This dissertation will attempt to determine differences in the association between 
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chronic sleep disturbances and diabetes by gender, as well as by race and ethnicity where 
possible. One of the hallmarks of an aging population is the increase in chronic conditions, such 
as diabetes, hypertension, arthritis, and the comorbidity of such conditions (75-76). While 
mortality rates due to infectious diseases and childbirth have declined, women are now at greater 
risk for comorbid chronic conditions later in life than ever before. Identifying modifiable risk 
factors, such as chronic sleep disturbances, allows for the prevention, detection and intervention 
to reduce the unnecessary burden associated with comorbidity of chronic conditions. 
Identification of such risk factors is becoming ever more important in an aging, diverse society. 
As with other chronic conditions, prevention as well as early detection of insufficient quality 
sleep, or chronic sleep disturbances, is necessary in order to provide the necessary treatment and 
decrease the risk of poor physical and mental health effects that can ensue from chronic sleep 
disturbances. 
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Chapter 2  Chronic Sleep Disturbances are Associated with Incident Diabetes in Older 
Adults: Variations by Gender and Race/Ethnicity 
Abstract 
Study Objectives: The current study was conducted to determine whether self-reported chronic 
sleep disturbances are predictive of incident diabetes in older adults, as well as to determine 
variations by gender and race/ethnicity. 
Methods: 7446 participants from the Health and Retirement Study, a nationally-representative 
longitudinal cohort study of U.S. adults, were followed for eight years, between 2006 and 2014. 
Chronic sleep disturbance was defined as self-reported trouble falling asleep or staying asleep 
“most of the time”. Diabetes was based on self-reported doctor’s diagnosis or a Hemoglobin 
A1C value >=6.5mg/dl. Hazard ratios were calculated for baseline and on-going sleep 
disturbances.  
Results: The average age of participants was 63.5 years. Close to 30% of men and 40% of 
women reported having a chronic sleep disturbance at baseline. The cumulative incidence over 
the eight year study period of diabetes was 17.7% among men and 15.2% among women. Both 
men and women who developed diabetes were more likely to report chronic sleep disturbances at 
baseline than those who did not develop diabetes (Men: 32.2% vs 27.3%; Women: 44.2% vs 
36.0%). Women were more likely to develop diabetes within eight years than men after 
adjustment for demographic covariates (Women: HR 1.40 95% CI 1.19-1.63; Men HR 1.27 95% 
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CI 0.98-1.66). Black and Hispanic men and women with chronic sleep disturbances had a greater 
likelihood of developing diabetes within eight years than white men and women. 
Conclusions: Self-reported chronic sleep disturbance is an independent predictor of incident 
diabetes in women. The likelihood of developing diabetes among those with chronic sleep 
disturbances is greater for women than men and greater for Blacks and Hispanics than non-
Black/Hispanic older adults. This finding has both public health and clinical relevance in an 
aging society. 
Key words: sleep quality, sleep disturbance, gender, incident diabetes, hazards ratio, aging, 
cohort study 
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Statement of Significance 
This longitudinal, population-based study is one of the first in the U.S. to demonstrate the 
increased hazard of developing diabetes associated with chronic sleep disturbances in Black and 
Hispanic women. Previous studies have primarily focused on sleep duration rather than sleep 
quality and on non-Hispanic/non-Black populations. The methods and findings of this study 
allow for the detection of a robust association between chronic sleep disturbances and incident 
diabetes taking into account changes in risk factors over time. Future studies should further 
explore gender-based differences over time as well as among younger adults of Black and 
Hispanic descent. The public health and clinical implications of sleep disturbances must be 
acknowledged at the population level as well as individual level in an aging society with rapid 
increases in the prevalence of both sleep disturbances and diabetes. 
Introduction 
Sleep disturbances are gaining increasing attention as a primary cause, or contributor, in 
the development and progression of chronic diseases (1-11). Sleep disturbances may include 
insomnia, a sleep disorder characterized by either the inability to fall asleep or difficulty staying 
asleep (i.e. broken sleep), as well as those related to medical conditions such as sleep apnea, 
restless leg syndrome and nocturia (12). The global burden of poor sleep is increasing, with 
women typically reporting higher levels of sleep disturbance and poor quality sleep than men 
(13). It is estimated that over 40 million American workers, approximately 30% of the work 
force, do not get sufficient sleep on a regular basis (13) and recent Centers for Disease Control 
(CDC) data shows that over nine million Americans take prescription sleeping aides on a daily 
basis (14). In an attempt to address the high levels of sleep disturbances in the United States, the 
CDC included a goal in the Healthy People 2020 objectives to increase the rate of sufficient 
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sleep among adults to seven hours or more per 24-hour period (15-16). Disparities in sleep 
duration and sleep quality have been identified for women, compared to men, and among Black 
adults compared to white and Hispanic adults (17-23).  
Public health concerns related to poor quality sleep are multi-factorial and include not 
only the development of chronic diseases, but also lost days of work, decreased quality of life 
and increased medical and prescription costs associated with sleep disturbance. While sleep itself 
is a basic biological need, poor quality sleep can lead to the inability to fight off infection, 
perform well in school and work, and metabolize sugar to prevent diabetes. Poor sleep has been 
linked to multiple diseases and chronic conditions including obesity, diabetes, cardiovascular 
disease, stroke and even mortality (1-11).  The prevalence and incidence of type II diabetes has 
increased substantially over the past decade and continues to rise worldwide (25-27) with the 
greatest risk in the U.S. among Black and Hispanic adults (28). Similarly, the increased 
incidence of diabetes raises the risk of other diabetic complications, lost employment time and 
wages, increased medical care costs, higher rates of comorbidity with other chronic conditions 
and mortality (29). Thus, not only is prevention of the onset of Type II diabetes an important 
public health concern, prevention of the progression of comorbid conditions is important once a 
diagnosis is received.  
Numerous studies, primarily cross-sectional, have examined the association between 
sleep duration, and to a lesser degree sleep quality, and incident diabetes in adult populations 
(30-42). Yet, a gap exists in the current literature in the role of poor sleep quality and diabetes 
among a nationally representative, longitudinal, sample of multi-ethnic older women and men in 
the United States. Most studies to date are of populations of European/Asian descent and few 
have sufficient sample sizes of Black or Hispanic populations to report associations among these 
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subgroups. Given the higher rates of sleep disturbances reported by Black adults and the higher 
rates of obesity, hypertension and type II diabetes among Black and Hispanic adults, 
understanding the role of sleep disturbances in the development of diabetes could provide 
information that has both clinical relevance as well as public health implications. Additionally, 
most studies assess risk in younger adults whereas the incidence of diabetes increases as adults 
age. Given the aging population, shifting demographics and the increase in diabetes in the United 
States, there is a need to examine these associations differentially by gender as well as by 
race/ethnicity within gender. 
In this study, we assessed the longitudinal association between poor sleep quality and 
incident diabetes. The study addressed two primary questions: 1) Is poor sleep quality associated 
with incident diabetes within eight years among older home-dwelling adults and, 2) Does this 
association vary by gender and race/ethnicity? Additionally, the impact of changes over time 
among known risk factors will be assessed as well. 
Methods 
Participants 
Health and Retirement Study 
Participants were drawn from the Health and Retirement Study (HRS). The HRS is a national, 
longitudinal study representative of the U.S. population aged 51 and older. The study began in 1992 and 
includes a new cohort of individuals age 50-55 every six years in order to maintain representation of the 
U.S. population in this age group as well as the older age groups as the study sample ages. Panel 
participants are interviewed every two years by phone or in person. The complex sample design, 
including oversamples of Black and Hispanic participants, allows for broad population-based inferences 
(43-45). The Health and Retirement Study is approved by the University of Michigan Institutional 
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Review Board (46). The Health and Retirement Study (HRS) is sponsored by the National Institute on 
Aging (grant number NIA U01AG009740) and is conducted by the University of Michigan. 
Study Sample 
Participants for the current study were selected from those who completed an HRS interview in 
2006.  Figure 2.1 provides a description of the sample. A total of 7,446 participants (4668 women, 2778 
men) were included in the current study ranging in age from 52-96. These participants were alive through 
2014 and completed biannual interviewer-assisted interview between 2006 to 2014. Participants did not 
have a diagnosis of diabetes at the start of the study. Participants who were interviewed by proxy or 
resided in a nursing home were not eligible for inclusion in the study.  
Measures 
Self-reported measures of demographic characteristics and health status were collected at 
each two-year period.  
Exposure: Sleep disturbances 
Participants were asked three questions related to sleep disturbance in 2006, 2010 and 
2014. The three questions were summed to create the exposure variable to assess chronic sleep 
disturbances. 
Disturbances in sleep quality were assessed based on self-reported frequency of having 
trouble falling asleep, waking up during the night and waking up too early and not being able to 
fall back asleep. Responses were dichotomized for each of the three questions to 1=Yes (Most of 
the time) or 0=No (Sometimes, rarely or never) in order to capture ongoing, chronic sleep 
disturbances. The number of sleep disturbance problems endorsed was calculated by summing 
the response to these three questions. A composite variable was created to categorize those who 
reported that they had one or more sleep problems most of the time.  
Outcome: Incident diabetes 
 29 
Incident diabetes was defined as self-reported diabetes in any wave of follow-up or a 
hemoglobin A1C  (HbA1c) result of 6.5mg/dL or greater, assayed from a non-fasting dried blood 
spot collected in the home at the time of the interview (28). 
Covariates: Demographic, health behaviors, health conditions  
Demographic variables included age calculated based on self-reported year of birth, 
gender, years of education and race/ethnicity. Respondents were categorized as Hispanic, non-
Hispanic Black, non-Hispanic White/Other based on responses to two separate questions on 
Hispanic ethnicity and race. Socio-economic status (SES) at baseline was calculated based on 
tertiles of total wealth obtained from the HRS-RAND economic data. This measure of total 
wealth included all income and assets of the respondent and other household members, such as a 
spouse or partner. Gender-specific tertiles were calculated and participants were categorized as 
low SES, middle SES and high SES based on the tertile of total wealth. Marital status and 
employment were asked at each interview. Marital status was coded as currently married versus 
not married (including never married, separated/divorced and widowed). Work status was coded 
as currently working or not working. Marital and employment status were considered time-
varying covariates. 
Health behaviors of interest included self-reported measures of physical activity, current 
smoking status and current alcohol consumption. Participants who reported engaging in 
moderate or vigorous physical activity at least once a week on average were considered to be 
physically active. Respondents who reported that they were current cigarette smokers were 
categorized as smokers. Current alcohol consumption on two or more days per week was 
categorized as positive for alcohol consumption. Health behaviors were collected during each 
interview. 
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Other health conditions that were potential confounders or moderators in the association 
between chronic sleep disturbances and incident diabetes were included based on self-report 
(Has a doctor or other medical professional ever told you that you have…”). Health conditions of 
interest included hypertension, heart disease, stroke, lung diseases, cancer, emotional, nervous or 
psychiatric problems (such as depression, anxiety), chronic pain and urinary incontinence. Body 
mass index (BMI) was calculated based on self-reported height and weight. A BMI of 30 or 
greater was considered obese. Health conditions were assessed at each biannual interview. 
Statistical Analysis 
A longitudinal dataset was created with responses from interviews conducted in 2006, 
2008, 2010, 2012 and 2014, with 2006 considered the baseline wave for the current analysis. 
Descriptive data analysis of all baseline characteristics was conducted for all of the sample as 
well as with the exposure variables as well as the outcome variables. Mean values of continuous 
variables were compared using t-tests.  Rao-Scott chi-square tests were utilized to assess the 
bivariate associations of categorical variables. All reported values were weighted for survey 
design and non-response. Survey-specific procedures were used to compute 95% confidence 
intervals to account for the multi-stage clustered sample design. Differences between those with 
and without diabetes were estimated using the overall Wald test. The cumulative incidence of 
diabetes was calculated overall and by gender. Population years of follow-up were used to 
calculate crude incidence rates by gender and race/ethnicity. A priori knowledge of risk factors 
for the development of type II diabetes were included as covariates in Cox proportional hazards 
models. Multiple Cox proportional hazards models were estimated to assess the proportional 
hazard of developing diabetes among those with chronic sleep disturbances at baseline compared 
to those without a chronic sleep disturbance. Cox proportional hazards models were stratified by 
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gender to account for the differences by gender in the exposure and the outcome. A series of six 
Cox proportional hazards models were estimated to determine the marginal impact of different 
covariates of interest on the association of the baseline exposure and outcome. The first model 
was unadjusted to determine the association between the exposure variable, one or more chronic 
sleep disturbances at baseline, and the development of diabetes over time. Model Adjusted-1 
adjusted for age at baseline and race/ethnicity as well as having one or more chronic sleep 
disturbance at baseline. Model Adjusted-2 adjusted for variables from the previous model as well 
as socio-economic status. Model Adjusted-3 adjusted for variables from the previous model as 
well as two health predictors- obesity and hypertension. Model Adjusted-4 adjusted for variables 
from the previous model as well as health behavior variables- physical activity, alcohol use and 
smoking status. Model Adjusted-5 adjusted for variables from the previous model as well as 
other chronic health conditions—heart disease, chronic pain, emotional problems and 
incontinence—as well as other lifestyle factors (marital and employment status). The seventh 
model included all of the baseline variables in the previous model as well as time-varying 
covariates for the follow up years 2008-2014. This seventh Cox proportional hazards model was 
estimated to adjust for time-varying exposure variables and covariates including biannual 
changes in chronic sleep disturbances, marital status, employment status, physical activity, 
alcohol consumption, smoking, hypertension, obesity, heart disease, incontinence, emotional 
problems and chronic pain. Interaction terms for race/ethnicity and obesity, race/ethnicity and 
hypertension and race/ethnicity and chronic sleep disturbances were assessed in models 6 and 7. 
Hazard ratios and 95% confidence intervals were calculated for all covariates in each model (47). 
The complex sample design characteristics (strata, cluster and respondent weights) were utilized 
at all stages of analysis (proc surveymean, proc surveyfreq, proc surveyphreg) (48). All 
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percentages and mean values reported are weighted for the complex sample design. All statistical 
tests were two-sided at a significance level of .05.  SAS v9.4 was used for data analysis.  
Results 
Close to six-tenths of the study population were female (58.4%) and the average age of 
all participants was 63.5 (SE 4.9, range 50-96). Just under fifteen percent of the study population 
were Black or Hispanic (7.7% and 6.4% respectively). Over half of participants had some 
college or a college degree (54.9%) and over half were working at baseline (51.2%). Over 
seventy percent of men and women reported engaging in physical activity on a weekly basis. 
Fourteen percent reported currently smoking and close to one-third of all respondents reported 
alcohol consumption on two or more days per week (28.6%). Men reported engaging in weekly 
physical activity, smoking and consuming alcohol more frequently than women. Overall, 
hypertension was the most prevalent health condition (45.7%) followed by obesity (31.5%), 
chronic pain (30.5%), heart disease (16.6%) and emotional or psychiatric problems (16.1%). 
Women were more likely to be hypertensive, report chronic pain and emotional/psychiatric 
problems than men. Men were more likely to report having heart disease than women (Table 
2.1). 
Baseline sleep disturbances by gender and race/ethnicity within gender are shown in 
Table 2.2. Women were more than twice as likely to report having difficulty falling asleep than 
men. Women were also more likely to report chronic problems with waking up at night and not 
falling back asleep and waking up too early in the morning and not falling back asleep. Overall, 
37.1% of women and 28.2% of men reported one or more chronic sleep problem. A lower 
proportion of both men and women reported that they rarely or never feel well rested when they 
wake up in the morning (14.0% men, 17.1% women). All differences between genders were 
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significant (p<0.0001). Among men, white males were more almost twice as likely to report 
chronic difficulties with waking up at night and not feeling well rested when waking up in the 
morning compared to Black and Hispanic males. Similar rates of Black and Hispanic men 
reported one or more chronic sleep problems (21.8% and 22.6%, respectively) while Hispanic 
men were more likely to report having problems waking up at night whereas Black men were 
more likely to report similar levels of disturbances waking up at night and waking up too early. 
Among women, significant differences were observed by race/ethnicity for chronic disturbances 
waking up at night, waking up too early in the morning and having one or more chronic sleep 
disturbance. More variation was observed in women than in men by race/ethnicity within each 
type of disturbance. For example, Hispanic women were more likely than white and Black 
women to report chronic disturbances falling asleep at night (20.0% vs 14.8% vs 15.1%, 
respectively). White women were more likely to report chronic disturbances waking up at night 
than Black or Hispanic women (29.5% vs 20.6% vs 18.4%). Among both men and women, white 
participants were most likely to report chronic sleep disturbances followed by Hispanic 
participants with Black participants reporting the lowest rate of chronic sleep disturbances. 
However, the rate of sleep disturbances was very similar for Hispanic and Black participants 
overall and both were approximately 25% lower than white men, 20% lower than white women. 
The cumulative incidence rate of diabetes within the eight year follow-up period was 
15.6%. Table 2.3 shows the baseline characteristics of men and women by diabetic status in 
2014. Men were more likely to develop diabetes than women within the eight-year follow-up 
period (17.7% vs 15.2%). Participants who developed diabetes were more likely to be Black or 
Hispanic, have a lower education level, not be currently married or working and have lower SES 
at baseline than those who did not develop diabetes. These results were consistent for men and 
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women. Both men and women who developed diabetes were less likely to engage in weekly 
physical activity, more likely to smoke and less likely to consume alcohol on a weekly basis. In 
terms of chronic health conditions at baseline, participants that developed diabetes were more 
likely to have each of the chronic conditions assessed than those who did not develop diabetes, 
with two exceptions—cancer for both genders and emotional problems in women. 
Crude incidence rates of diabetes by gender, race/ethnicity and the presence or lack of 
presence of chronic sleep disturbances at baseline are shown in Table 2.4. Incidence rates were 
higher in men and women with chronic sleep disturbances compared to those without sleep 
disturbances at baseline. Black women and men with baseline chronic sleep disturbances had the 
highest rates of incident diabetes. While Hispanic women with baseline chronic sleep 
disturbances had the second highest crude incidence rate of diabetes, Hispanic men with and 
without sleep disturbances had higher rates of incident diabetes. For all subgroups, 8-year crude 
incidence rates of diabetes were higher among those who reported chronic sleep disturbances 
than those who did not. 
Cox proportional hazards models were calculated separately for men and women given 
the differences in the association of sleep and diabetes between and within gender. Seven models 
are shown in tables 2.5 (women) and in table 2.6 (men). In unadjusted models, we found that 
women with chronic sleep disturbances at baseline had a 37% greater proportional hazard of 
developing diabetes during the eight-year follow up period than those without diabetes (HR 1.37, 
95% CI 1.17-1.60). While men also had an increased likelihood of developing diabetes, the 
association approached significance but was not statistically significant (HR 1.25; 95% CI 0.96-
1.62). The hazard ratio of developing incident diabetes due to chronic sleep disturbances 
increased in both men and women after adjustment for demographic characteristics (adjusted 
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models 1 and 2). However, the association was attenuated after adjusting for additional lifestyle 
factors and chronic conditions (adjusted models 3-5). The greatest reduction in the hazard ratio 
for sleep disturbances was observed when hypertension and obesity are incorporated in the 
models. This pattern is consistent for men and women. First order interaction terms among sleep, 
hypertension and obesity were not significant for men or women. 
After adjusting for all other covariates (adjusted model 5), women with one or more 
chronic sleep disturbance at baseline had a hazard ratio of 1.29 (95% CI 1.11-1.49) of developing 
diabetes within eight years. Other covariates that were significant predictors of developing 
diabetes were age, being Black or Hispanic, being obese and having hypertension. Regular 
alcohol consumption was protective of developing diabetes within eight years among women. In 
men, after adjusting for all other covariates, those with one or more chronic sleep disturbances at 
baseline had a hazard ratio of 1.22 (95% CI 0.94-1.57) of developing diabetes within eight years. 
Thus, in men, the association between chronic sleep disturbances and incident diabetes 
approached significance after taking time-varying covariates into account. Other covariates that 
were significant predictors of developing diabetes in men were being Black or Hispanic, low 
SES, being obese, having hypertension and having heart disease. Regular alcohol consumption 
and being married appear protective of developing diabetes within eight years among men.  
The incorporation of time-varying covariates (sleep disturbances, obesity, high blood 
pressure, pain, depression, heart disease, physical activity, alcohol consumption, marital status 
and work status) slightly attenuated the hazard ratio in both men and women, yet the association 
remained significant in women (Adjusted-Time-Varying). After adjustment for time-varying 
lifestyle and health conditions, women with chronic sleep disturbances at baseline had a 27% 
greater hazard of developing diabetes over the eight-year follow up period compared to those 
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who did not have chronic sleep disturbances at baseline (HR 1.27; 95% CI 1.08-1.50). In men, 
the association between chronic sleep disturbances at baseline and the development of type II 
diabetes over the eight year follow-up period was attenuated after accounting for changes in 
lifestyle factors and health conditions over time (HR 1.14; 95% CI 0.88-1.48). However, the 
development of new sleep disturbances during the follow-up period were significantly associated 
with the development of incident diabetes in men, but not in women (Chronic sleep disturbances 
between 2008-2014- Women HR 1.03, 95% CI 0.81-1.29; Men HR 1.35, 95% CI 1.07-1.71. 
Data not shown). 
Discussion 
In this large, nationally-representative sample, we found that older adults with chronic 
sleep disturbances are more likely to develop diabetes within eight years than those without 
chronic sleep disturbances even after controlling for key confounders including age, 
race/ethnicity, socio-economic status, obesity and hypertension. Women reported chronic sleep 
disturbances more often than men (37.1% vs 28.2%). While the rate of incident diabetes was 
slightly lower in women than men, 15.2% vs 17.7%, women with chronic sleep disturbances 
were significantly more likely to develop diabetes within eight years than those who did not have 
chronic sleep disturbances. Differences by race and ethnicity within gender were detected. White 
women and men reported higher levels of chronic sleep disturbances compared to Black and 
Hispanic adults. However, the crude incidence of diabetes among those with chronic sleep 
disturbances is more than twice the rate in Black women compared to White women, and 75% 
greater in Hispanic women than non-Hispanic white women. Among men, the crude incidence 
rate of diabetes is also close to 80% greater in Black and Hispanic men with chronic sleep 
disturbances compared to white men. This association remains after controlling for multiple 
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factors as well as changes in risk factors over time. The hazard remains greatest among women. 
When evaluating race/ethnicity within gender, Hispanic women have the greatest hazard, 
followed by Black women. Among men, Black men have the greatest hazard followed by 
Hispanic men. This study shows that chronic sleep disturbances are a risk factor in the 
development of diabetes, especially among Black and Hispanic adults. Additionally, on-going 
sleep disturbances remain a significant predictor of incident diabetes in men. Those who develop 
diabetes within eight years are more likely to be Black or Hispanic, low income, not working, 
not married and have poorer health condition and health habits than those who do not develop 
diabetes.  
A systematic review by Cappuccio and colleagues (30) found that both sleep duration and 
sleep quality predict the risk of developing type II diabetes. The review included ten studies and 
found the greatest risk among those who reported difficulty initiating sleep (RR 1.57; 95% CI 
1.25-1.97) and difficulty maintaining sleep (RR 1.84; 95% CI 1.39-2.43). However, the review 
was unable to report differences in risk by gender nor by race/ethnicity. Many of the studies 
included were among non-ethnically diverse populations. Half of the studies included only one 
gender and could not detect differences by gender in the reference population. The other half of 
the studies did not report results separately by gender.  Additionally, the age of the study 
populations ranged from 19-69 with most studies assessing risk at 40 years of age. Thus, the 
association among older adults who developed diabetes may not have been detected. Each of the 
studies included assessed sleep disturbances based on questionnaires and self-report, similar to 
the current study. The review by Cappuccio and colleagues is useful in highlighting the risk of 
incident diabetes among adults with chronic sleep disturbances, however differences by 
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race/ethnicity were outside of the scope of the review and sleep quality in women was only 
assessed in studies conducted outside of the U.S..  
Meisinger and colleagues (34) found that difficulty maintaining sleep was associated with 
a higher risk of developing type II diabetes among adults age 25-74 with an average follow-up of 
7.5 years. In line with our findings, the hazard ratio in women was greater than in men (Women 
HR 1.98; 95% CI 1.20-3.29; Men HR 1.60; 95% CI 1.05-2.45). However, difficulty initiating 
sleep was not significantly associated with developing diabetes in men or women. The study 
population included participants from the MONICA study conducted in Germany, a racially and 
ethnically homogenous population. Additionally, the crude incidence rates of diabetes in men 
and women were much lower than those detected in our study population. Hoevenaar-Blom and 
colleagues (3) found that short sleep duration accompanied by sleep disturbances increased the 
risk of incident cardiovascular disease after 10-15 years of follow up. However, this study was a 
population-based study in the Netherlands and was unable to detect or report differences by 
gender or race/ethnicity. 
Numerous studies have reported increased rates of sleep disturbances among Black and 
Hispanic adults in the U.S. population. Many of these focus on psychosocial stressors and socio-
economic conditions associated with sleep disturbances (17--23). To date, studies assessing the 
relationship between poor sleep quality and diabetes in racially and ethnically diverse 
populations are few and have been cross-sectional in nature. Thus, the relationship between poor 
quality sleep and incident diabetes in non-white populations has not been assessed. The Multi-
Ethnic Study of Atherosclerosis (MESA) included 2230 participants with an average age of 68.8 
(22).  Multiple measures of sleep quality were used including polysomnography, actigraphy and 
a self-reported questionnaire.  Chen and colleagues found that Blacks had higher rates of sleep 
 39 
apnea, short sleep, poor sleep quality and daytime sleepiness than whites. Hispanics had higher 
odds of sleep apnea and short sleep. Black men and Hispanic women more likely to report poor 
sleep quality. The odds of poor sleep quality decreased with age in Blacks but increased among 
Hispanics. While the Chen et al study concludes that Blacks and Hispanics may be at an 
increased risk for the development of chronic conditions related to poor sleep, this cross-
sectional study did not report on the association between chronic conditions and sleep 
disturbances.  
Previous studies have focused primarily on the association between sleep duration and 
diabetes. These studies have found a positive association between both short sleep duration and 
long sleep duration with the onset of diabetes, as well as short sleep duration accompanied by 
sleep disruption. Using data from the National Health Interview Survey, a cross-sectional 
population-based study, Zizi and colleagues found that both Black and White participants 
reporting either short sleep duration, less than 6 hours, or long sleep duration, greater than 8 
hours, were at an increased odds of having diabetes than those who slept 6-8 hours per night 
(38). The association was greater for Blacks than whites. A study by Beihl and colleagues 
showed that short sleep duration (7 hours or less) was a risk factor for incident diabetes in 
Hispanics and Whites, but not in Blacks, after five years of follow-up (37). Vgontzas and 
colleagues invited participants with self-reported insomnia lasting a year or more, or poor quality 
sleep, to a sleep laboratory to determine the joint effect of an objective measure of short sleep 
duration and insomnia (10). They found that participants were at a greater risk of diabetes if they 
had chronic insomnia combined with short sleep duration, 5 hours of sleep a night or less. Poor 
sleep alone was not associated with diabetes. Knutson and colleagues found that Hispanic adults 
with delayed sleep timing were at an increased risk of incident diabetes compared to those who 
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reported earlier bedtimes (36). Of the few longitudinal studies on the effects of sleep quality, the 
health outcomes of interest have varied including cardiovascular disease, hypertension, obesity, 
diabetes and quality of life. A longitudinal study conducted by Grossman and colleagues with 
older adults in Europe found a positive association between persistent sleep problems over six 
years of follow up and lower quality of life as well as decreased ability to conduct activities of 
daily living (11). 
The current study has several strengths that should be noted. The results are based on a 
large population-based cohort that has employed a complex sample design allowing for both 
population-based inferences and subgroup analyses. This has allowed us to detect differences in 
the association between diabetes and chronic sleep disturbances by gender. Additionally, the 
outcome of incident diabetes included both those with undetected diabetes as well as self-
reported diabetes. Over 30% of those with incident diabetes were categorized as such based on 
their HbA1C value rather than self-report of a diagnosis. While the detection via A1C rather than 
self-report varied slightly by race/ethnicity (24% of Hispanic diabetics, 37.5% of Black diabetics 
and 32.9% of white diabetics), the overall association did not change significantly when the 
analysis were restricted to those who self-reported a diagnosis of diabetes. Previous studies have 
assessed difficulty initiating sleep and difficulty maintaining sleep separately whereas we have 
grouped these disturbances together in the current study. If these sleep quality disturbances have 
different effects on the development of diabetes, as shown by Meisinger et al (34), the effect of 
sleep disturbances on incident diabetes may be underestimated in our study. However, a separate 
analysis not included in this paper, found that the results were not changed when assessing these 
measures as separate exposures.  
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Our study has potential limitations. Both the exposure, chronic sleep disturbances, and 
the outcome, incident diabetes, were based on self-report and could lead to measurement error. 
Additionally, the exposure was subjective and it was not possible to validate self-reported sleep 
quality with an objective measure of sleep such as polysomnography or actigraphy. Previous 
studies have found that men tend to under-report sleep disturbances. Given the difference in 
sleep disturbance rates among men and women, it is possible that the men in our study 
population underreported chronic sleep disturbances. This may have contributed to our inability 
to detect a significant relationship between sleep disorders and incident diabetes among men 
despite the indication that one exists. Our study is based on interview data and did not include 
measures, either self-report or objective measures, of sleep apnea, snoring, or family history of 
diabetes. Thus, it is possible that self-reported chronic sleep disturbances could be proxy 
measures of sleep apnea. It is possible that confounding due to unmeasured risk factors occurred 
in our study results. Our study is based on complete case analysis among an older adult 
population over eight years of follow-up.  If the reason for nonresponse or death was related to 
either the exposure or the outcome, our results may show an attenuated association between the 
exposure and outcome. Given the age range at baseline of our study participants, mortality could 
be a competing risk. 
In conclusion, our study provides evidence of a robust independent relationship between 
chronic sleep disturbances and the development of diabetes in older adults, and that the hazard is 
greater among women and Black and Hispanic adults. In women, sleep disturbances at baseline 
are predictive of incident diabetes within eight years whereas among men, variations in sleep 
disturbances over time are more predictive. Future studies should be undertaken to replicate our 
results with larger populations of racially and ethnically diverse adults. Psychosocial factors 
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associated with poor quality sleep in these populations should be taken into account as well as 
determining the age at which risk begins to increase. The findings of this study have both clinical 
and public health significance in a diverse and aging society. 
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Figure 2.1 Study population. 
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 Men Women All 
 
n=2,778 
(41.6%) 
n=4,668 
(58.4%) 
n=7,446 
(100%) 
Demographic Characteristics % (SE) % (SE) % (SE) 
Age (mean yrs, SE) 62.9 (4.9) 63.9 (5.3) 63.5 (4.9) 
Race/Ethnicity    
   White/other, non-Hisp 87.1 (1.0) 84.9 (1.1) 85.8 (0.9) 
   Black, non-Hisp 6.8 (0.6) 8.4 (0.6) 7.7 (0.5) 
   Hispanic 6.1 (0.8) 6.7 (1.0) 6.4 (0.8) 
Education (mean yrs, SE) 13.9 (0.1) 13.3 (0.1) 13.6 (0.1) 
   HS degree or less 39.5 (1.3) 49.1 (1.1) 45.1 (1.0) 
   Some college or degree 60.5 (1.3) 50.9 (1.1) 54.9 (1.0) 
Currently married 74.5 (1.2) 61.4 (0.9) 66.8 (0.8) 
Currently working 58.5 (1.2) 46.1 (0.9) 51.2 (0.8) 
SES tertiles (%, SE)    
     Low 35.2 (1.4) 32.0 (1.3) 33.3 
     Middle 32.0 (1.2) 32.8 (0.8) 33.3 
     High 32.8 (1.5) 35.2 (1.3) 33.3 
    
Health Behaviors    
   Weekly moderate or vigorous  
physical activity 76.7 (1.2) 70.0 (0.9) 72.8 (0.8) 
   Current smoker 15.8 (1.0) 12.8 (0.6) 14.1 (0.6) 
   Alcohol use >= 2d/week 37.7 (1.3) 22.1 (0.9) 28.6 (0.9) 
    
Health Conditions    
   Hypertension 44.9 (1.3) 46.3 (0.9) 45.7 (0.8) 
   Heart disease 19.9 (1.0) 14.2 (0.6) 16.6 (0.6) 
   Stroke 3.3 (0.4) 2.7 (0.2) 2.9 (0.2) 
   Lung disease 5.8 (0.4) 8.0 (0.5) 7.1 (1.2) 
   Cancer 11.0 (0.7) 11.3 (0.4) 11.2 (0.4) 
   Emotional/psychiatric problem 11.2 (0.8) 19.6 (0.7) 16.1 (0.5) 
   Pain 26.0 (0.9) 33.7 (0.9) 30.5 (1.5) 
   Urinary incontinence 2.2 (0.3) 11.7 (0.5) 7.7 (0.4) 
   BMI (mean, SE) 28.6 (0.1) 28.5 (0.1) 28.5 (0.1) 
   Obese (BMI>=30) 31.0 (1.0) 31.9 (1.0) 31.5 (0.7) 
SES: Socio-economic status, BMI: Body mass index, SE: standard error. All percentages and standard 
errors weighted for complex sample design features. 
 
Table 2.1. Baseline characteristics of the study population (weighted) 
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        Men   Women   
  Men Women   White Black Hispanic   White Black Hispanic   
  % (SE)  % (SE) p % (SE) % (SE)  % (SE)  p % (SE)  % (SE) % (SE)  p 
Trouble Most of the Time n=2778 n=4668   n=2310 n=264 n=204   n=3697 n=607 n=364   
   Falling Asleep 6.9 (0.7) 15.1 (0.8) <0.001 6.7 (0.7) 9.2 (2.6) 7.2 (2.0) 0.550 14.8 (0.9) 15.1 (1.3) 20.0 (2.8) 0.100 
   Waking up at night 21.8 (0.9) 28.0 (0.8) <0.001 23.0 (1.0) 12.0 (2.0) 15.2 (3.2) 0.001 29.5 (0.9) 20.6 (1.7) 18.4 (2.6) 0.001 
   Waking up too early in morning 9.9 (0.7) 13.8 (0.6) <0.001 9.9 (0.7) 11.9 (2.8) 8.6 (2.2) 0.602 13.3 (0.7) 14.5 (1.3) 18.7 (2.2) 0.016 
   1+ chronic sleep problems 28.2 (1.1) 37.1 (0.9) <0.001 29.1 (1.2) 21.8 (3.0) 22.6 (4.4) 0.073 38.2 (1.1) 30.5 (1.9) 31.7 (3.3) 0.009 
*All percentages are weighted and standard errors (SE) account for the complex sample design. Comparisons between and within gender with Rao-Scott Chi-square test 
statistic. Significant values in bold (p<0.05) 
Table 2.2. Prevalence of chronic sleep disturbances at baseline by gender and race/ethnicity*. 
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 Men Women 
 
Not diabetic Incident 
diabetes 
Not 
diabetic 
Incident 
diabetes 
 n=2,286  n=492  n=3,957  n=711  
 % (SE) % (SE) % (SE) % (SE) 
2006 Demographic Characteristics     
Age (mean yrs, SE) 62.9 (5.3) 62.7 (6.8) 64.0 (5.5) 63.6 (6.7) 
Race/Ethnicity     
   White/other, non-Hisp 88.7 (1.0) 79.4 (2.5) 86.8 (1.0) 73.7 (2.1) 
   Black, non-Hisp 5.8 (0.6) 11.6 (1.6) 7.2 (0.6) 15.2 (1.6) 
   Hispanic 5.5 (0.7) 9.0 (1.7) 6.0 (0.9) 11.1 (1.8) 
Education (mean yrs, SE) 14.0 (0.1) 13.2 (0.2) 13.4 (0.1) 13.0 (0.3) 
   HS degree or less 38.1 (1.4) 46.4 (2.7) 47.9 (1.1) 55.9 (2.2) 
   Some college or degree 61.9 (1.4) 53.6 (2.7) 52.1 (1.1) 44.1 (2.2) 
Currently married 75.4 (1.4) 69.9 (2.3) 62.5 (1.0) 55.0 (2.2) 
Currently working 59.1 (1.2) 55.8 (2.7) 45.9 (1.0) 46.8 (2.2) 
SES Low 33.0 (1.5) 45.5 (3.1) 30.0 (1.4) 43.9 (2.2) 
SES Middle 32.2 (1.3) 30.8 (2.8) 33.1 (0.9) 31.2 (1.8) 
SES High 34.8 (1.6) 23.7 (2.4) 36.9 (1.4) 24.9 (2.0) 
2006 Health Behaviors     
   Weekly moderate or vigorous physical activity 77.3 (1.2) 73.9 (2.2) 70.9 (1.0) 64.8 (2.3) 
   Current smoker 15.5 (1.0) 16.9 (2.0) 12.7 (0.6) 13.5 (1.3) 
   Alcohol use >= 2days/week 39.3 (1.4) 29.6 (2.5) 23.7 (1.0) 12.4 (1.4) 
2006 Health Conditions     
   Hypertension 41.5 (1.5) 61.0 (2.4) 43.3 (0.9) 63.8 (2.1) 
   Heart disease 18.2 (0.9) 27.5 (2.5) 14.0 (0.5) 15.6 (1.6) 
   Stroke 3.1 (0.3) 4.4 (1.0) 2.4 (0.3) 3.9 (0.7) 
   Lung disease 5.6 (0.5) 7.0 (1.4) 7.5 (0.5) 11.0 (1.3) 
   Cancer 11.1 (0.7) 10.4 (1.5) 11.4 (0.5) 10.7 (1.1) 
   Emotional/psychiatric problem 11.3 (0.9) 10.9 (1.7) 18.9 (0.8) 23.4 (1.7) 
   Pain 25.1 (1.1) 30.1 (2.3) 32.6 (0.9) 40.4 (2.1) 
   Urinary incontinence 2.0 (0.4) 2.6 (0.8) 11.1 (0.6) 14.9 (1.3) 
   BMI (mean, SE) 28.0 (0.1) 31.4 (0.3) 28.0 (0.1) 31.1 (0.3) 
   Obese (BMI>=30) 26.6 (1.1) 52.0 (2.7) 28.7 (1.0) 51.0 (1.9) 
2006 Sleep Disturbances     
   Chronic trouble falling asleep 6.4 (0.7) 9.5 (1.7) 14.2 (0.8) 20.5 (1.7) 
   Chronic trouble waking up at night 21.3 (1.0) 24.2 (2.6) 27.2 (0.9) 32.3 (2.0) 
   Chronic trouble waking too early in morning 9.4 (0.7) 12.4 (2.0) 13.3 (0.7) 16.6 (2.1) 
   1+ chronic sleep disturbance 27.3 (1.3) 32.2 (2.8) 36.0 (1.1) 44.2 (1.8) 
Baseline characteristics measured in 2006. Incident diabetes as reported between 2008-2014. SES: Socio-economic status, BMI: Body 
mass index, SE: standard error. All percentages and standard errors weighted for complex sample design features. 
Table 2.3. 2006 baseline characteristics and diabetic status over prospective follow-up 2006-2014. 
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Men   
>= 1 Chronic 
Sleep 
Disturbance   Women   
>= 1 Chronic 
Sleep 
Disturbance 
All   Yes No   All   Yes No 
n=2,778 Number of individuals 800 1978   n=4,668 Number of individuals 1700 2968 
  # incident diabetes 152 340    # incident diabetes 295 416 
  Person Years (PY) 6400 15824    Person Years (PY) 13600 23744 
  Crude incidence per 10,000 PY 237.5 214.9     Crude incidence per 10,000 PY 216.9 175.2 
Black         Black       
n=264 Number of individuals 57 207   n=607 Number of individuals 178 429 
  # incident diabetes 18 57    # incident diabetes 57 100 
  Person Years (PY) 456 1656    Person Years (PY) 1424 3432 
  Crude incidence per 10,000 PY 394.7 344.2     Crude incidence per 10,000 PY 400.3 291.4 
Hispanic       Hispanic       
n=204 Number of individuals 41 163   n=364 Number of individuals 115 249 
  # incident diabetes 11 44    # incident diabetes 30 56 
  Person Years (PY) 328 1304    Person Years (PY) 920 1992 
  Crude incidence per 10,000 PY 335.4 337.4     Crude incidence per 10,000 PY 326.1 281.1 
White         White       
n=2,310 N 702 1608   n=3,697 Number of individuals 1407 2290 
  # incident diabetes 123 239    # incident diabetes 208 260 
  Person Years (PY) 5616 12864    Person Years (PY) 11256 18320 
  Crude incidence per 10,000 PY 219.0 185.8     Crude incidence per 10,000 PY 184.8 141.9 
Crude incidence rates of diabetes after 8 years of follow-up. Incident diabetes based on self-report or hemoglobin A1C >=6.5 mg/dl. 
 
 
Table 2.4. Eight-year follow-up rates of diabetes by chronic sleep disturbance, gender and race/ethnicity. 
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  Unadjusted Adjusted-1 Adjusted-2 Adjusted-3 Adjusted-4 Adjusted-5 
Adjusted-Time 
Varying 
1/+ Sleep Problems 1.37 (1.17-1.60) 1.43 (1.23-1.67) 1.40 (1.19-1.63) 1.31 (1.12-1.53) 1.30 (1.11-1.51) 1.29 (1.11-1.49) 1.27 (1.08-1.50) 
Age 
 1.24 (1.05-1.45) 1.27 (1.08-1.50) 1.21 (1.04-1.42) 1.21 (1.04-1.41) 1.22 (1.05-1.43) 1.23 (1.06-1.43) 
Black  2.35 (1.88-2.93) 1.96 (1.56-2.44) 1.59 (1.28-1.98) 1.57 (1.26-1.95) 1.59 (1.28-1.98) 1.56 (1.25-1.95) 
Hispanic  2.07 (1.62-2.65) 1.80 (1.39-2.33) 1.81 (1.37-2.38) 1.75 (1.33-2.31) 1.80 (1.37-2.37) 1.77 (1.33-2.35) 
Low SES   1.69 (1.36-2.10) 1.40 (1.12-1.76) 1.28 (1.02-1.61) 1.20 (0.95-1.53) 1.18 (0.92-1.50) 
Middle SES   1.30 (1.05-1.62) 1.19 (0.95-1.49) 1.14 (0.91-1.42) 1.10 (0.88-1.37) 1.08 (0.86-1.34) 
Obese    1.89 (1.59-2.26) 1.84 (1.54-2.19) 1.83 (1.55-2.17) 1.68(1.32-2.13) 
Hypertension    1.76 (1.47-2.11) 1.76 (1.47-2.11) 1.78 (1.47-2.14) 1.35(1.09-1.67) 
Physical activity     0.98 (0.80-1.18) 0.97 (0.80-1.18) 0.98 (0.79-1.20) 
Alcohol use     0.62 (0.48-0.81) 0.61 (0.47-0.80) 0.75 (0.55-1.02) 
Current smoker     1.12 (0.88-1.43) 1.11 (0.87-1.41) 1.07 (0.77-1.51) 
Pain      1.01 (0.85-1.21) 1.04 (0.87-1.24) 
Emotional problems      1.15 (0.93-1.42) 1.16 (0.81-1.65) 
Incontinence      1.09 (0.86-1.38) 1.08 (0.81-1.43) 
Heart disease      0.93 (0.72-1.20) 0.83 (0.63-1.10) 
Currently married      0.90 (0.73-1.10) 0.76 (0.56-1.03) 
Currently working           1.21 (0.99-1.48) 1.15 (0.94-1.40) 
SES: socio-economic status; Reference groups: white, high socio-economic status. Values in bold are statistically significant. Adjusted models 1-5 are adjusted for the 
variables shown. Adjusted time-varying is adjusted for baseline values and time-varying values of obesity, hypertension, physical activity, alcohol use, smoking status, 
pain, emotional problems, incontinence, heart disease, marital status and employment status. 
 
 
Table 2.5. Cox proportional model estimates of hazard ratios of developing diabetes within 8 years of follow-up among women. 
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  Unadjusted Adjusted-1 Adjusted-2 Adjusted-3 Adjusted-4 Adjusted-5 
Adjusted-Time 
Varying 
1/+ Sleep Problems 1.25 (0.96-1.62) 1.29 (0.99-1.69) 1.27 (0.98-1.66) 1.23 (0.95-1.58) 1.22 (0.94-1.58) 1.22 (0.94-1.57) 1.14 (0.88-1.48) 
Age 
 1.24 (1.01-1.51) 1.28 (1.04-1.58) 1.20 (0.98-1.48) 1.21 (0.98-1.49) 1.22 (0.99-1.51) 1.21 (0.97-1.52) 
Black  2.11 (1.49-2.98) 1.79 (1.27-2.52) 1.63 (1.16-2.29) 1.57 (1.11-2.22) 1.59 (1.12-2.26) 1.62 (1.15-2.29) 
Hispanic  1.69 (1.20-2.39) 1.48 (1.06-2.07) 1.44 (1.01-2.05) 1.41 (1.00-1.99) 1.48 (1.05-2.09) 1.55 (1.10-2.19) 
Low SES   1.76 (1.33-2.32) 1.60 (1.23-2.08) 1.50 (1.15-1.96) 1.38 (1.05-1.83) 1.40 (1.05-1.85) 
Middle SES   1.36 (1.02-1.81) 1.24 (0.93-1.65) 1.20 (0.90-1.60) 1.16 (0.88-1.54) 1.15 (0.89-1.50) 
Obese    2.30 (1.82-2.91) 2.29 (1.82-2.90) 2.37 (1.87-3.02) 1.98 (1.52-2.59) 
Hypertension    1.65 (1.30-2.09) 1.67 (1.31-2.13) 1.58 (1.25-2.00) 1.19 (0.93-1.52) 
Physical activity     1.00 (0.82-1.22) 1.00 (0.83-1.22) 0.99 (0.82-1.20) 
Alcohol use     0.77 (0.61-0.98) 0.77 (0.61-0.98) 0.81 (0.60-1.08) 
Current smoker     1.16 (0.88-1.52) 1.13 (0.87-1.47) 1.27 (0.90-1.78) 
Pain      1.04 (0.83-1.30) 1.10 (0.85-1.43) 
Emotional problems      0.79 (0.53-1.16) 0.62 (0.40-0.97) 
Incontinence      1.08 (0.56-2.10) 1.28 (0.65-2.49) 
Heart disease      1.48 (1.19-1.83) 1.24 (0.95-1.64) 
Currently married      0.76 (0.59-0.97) 0.69 (0.47-1.00) 
Currently working           1.01 (0.77-1.33) 0.96 (0.72-1.30) 
SES: socio-economic status; Reference groups: white, high socio-economic status. Values in bold are statistically significant. Adjusted models 1-5 are adjusted for the 
variables shown. Adjusted time-varying is adjusted for baseline values and time-varying values of obesity, hypertension, physical activity, alcohol use, smoking status, 
pain, emotional problems, incontinence, heart disease, marital status and employment status. 
 
 
Table 2.6. Cox proportional model estimates of hazard ratios of developing diabetes within 8 years of follow-up among men. 
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Chapter 3 Type II Diabetes and the Development of Chronic Sleep Disturbances in Older 
Adults. 
Abstract 
Study Objective: Chronic sleep disturbances can lead to lack of glycemic control among 
diabetic and non-diabetic individuals. While previous studies have shown chronic sleep 
disturbances to be a risk factor in the development of diabetes, it is not known whether incident 
diabetes is associated with developing chronic sleep disturbances. This study assesses the odds of 
developing a chronic sleep disturbance within four years among adults with a recent diagnosis of 
diabetes compared to those with prevalent diabetes and those without a diagnosis of diabetes. 
Methods: Participants were selected from the Health and Retirement Study (n=8,015). 
Participants who completed an interview in 2010 and were free of chronic sleep disturbances 
were categorized as not diabetic, having a recent diagnosis of type II diabetes or as previously 
diagnosed with type II diabetes. Chronic sleep disturbances were assessed after four years and 
defined as self-reported trouble falling asleep, waking up at night or waking up too early most of 
the time. Logistic regression models were estimated to determine the odds of developing a 
chronic sleep disturbance after adjusting for demographic, lifestyle and health conditions.  
Results: At baseline, 5.3% of men and 2.9% of women reported a diagnosis of diabetes since 
2009. After four years, 29.1% of women and 19.3% of men reported onset of one or more 
chronic sleep disturbances. Although not significant, men and women without diabetes reported 
lower rates of sleep disturbances (16.7% and 18.6% respectively). Women with incident diabetes 
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had an 80% greater odds of developing a chronic sleep disturbance within four years than those 
without diabetes (OR 1.80; 95% CI 1.01-3.20). However, the odds were attenuated and no longer 
significant after adjusting for demographic, lifestyle and health conditions (OR 1.63; 95% CI 
0.86-3.12). While the direction of the association was similar in men, unadjusted and adjusted 
logistic models were not statistically significant (fully adjusted model OR 1.14; 95% CI 0.69-
1.90). 
Conclusions:  This study supports previous cross-sectional findings that a recent diagnosis of 
diabetes may increase the odds of developing a chronic sleep disturbance, especially in women. 
Given the negative effect of chronic sleep disturbances on glycemic control, the presence of 
sleep disturbances should be monitored among newly diagnosed diabetics. Early detection and 
intervention can reduce the additional burden and risk for deleterious outcomes in this growing 
population. 
Key words cohort, sleep disturbance, sleep quality, diabetes, incident 
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Introduction 
Diabetes is the most frequently diagnosed chronic condition and the chronic disease that 
is increasing at the most rapid rate in the world (1-4). Between 1980 and 2008, the U.S. 
population aged 65 and older experienced the greatest increase in the prevalence of diabetes with 
an increase from 8% to nearly 20% (5). Ensuring glycemic control among this population is 
critical to reduce the individual and societal burden related to poor glycemic control which 
includes increased treatments costs, lost days of work and reductions in quality of life. The costs 
associated with diagnosed diabetes are staggering at both the societal and individual level. In 
2008, it was estimated that one out of every five dollars spent on health care in the United States 
was spent on diabetic patients (6).  The total estimated cost of diagnosed diabetes was $174 
billion in 2007. In 2012, it was estimated that the total annual cost of diagnosed diabetes had 
increased to $245 billion, a 41% increase in five years.  Seventy-two percent (72%) of the $245 
billion was attributable to direct medical costs and the remainder due to lost productivity. At the 
individual level, the total annual health care costs of those with diagnosed diabetes are close to 
$14,000, likely due to the increased risk of comorbid conditions in this population. Close to 
$8,000, or 58% of the annual medical costs incurred, were attributable to the diagnosed diabetes 
including doctor’s visits, medical tests and medication. These increased health care costs are 
likely to come at a time in life in which health care coverage is extremely expensive and 
prescription coverage is limited for a large portion of the affected population.  Over two-thirds of 
these costs are covered by the government (Medicare, Medicaid, the military) and by uninsured 
individuals. With the cost of insulin increasing three-fold in the last ten years, the undue burden 
on our aging population must be addressed (7).  
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Both short term and chronic sleep disturbances, including sleep deprivation as well as 
sleep interruptions, impair glycemic control and reduce insulin sensitivity (8). While this is a 
concern for the population in general, reduced glycemic control is especially problematic among 
individuals with diabetes. Previous studies have shown disruptions in sleep duration as well as 
chronic sleep disturbances to be risk factors in the development of type II diabetes (9-18). 
Numerous cross-sectional studies have found that those with diabetes report sleep disturbances to 
a greater degree than those without diabetes (19-22). However, few studies have assessed 
whether incident diabetes is itself associated with the development of chronic sleep disturbances. 
There are several plausible mechanisms which may lead to the development of chronic sleep 
disturbances among individuals recently diagnosed with diabetes. This includes hyperglycemia 
experienced at night by those with diabetes which can lead to nocturia, a common reason for 
night wakening. Additionally, a period of adaptation to the new diagnosis, as well as new 
medications and required lifestyle changes, could lead to increased anxiety or depression both of 
which are associated with chronic sleep disturbances. Finally, it is likely that there is a bi-
directional relationship in the association between inflammation and inflammatory processes, 
such as increased C-reactive protein and interleukin 6, and sleep disturbances (8, 23). Given that 
individuals with diabetes and chronic sleep disturbances have an increased risk for poor health 
outcomes, determining whether newly diagnosed type II diabetes is associated with the 
development of chronic sleep conditions is important. Reduced glycemic control as a result of 
chronic sleep disturbances could potentially lead to decreased quality of life and accelerate other 
negative outcomes associated with diabetes. 
Several studies have demonstrated a U-shaped relationship between sleep duration and 
glycemic control (19). Among non-diabetic participants of NHANES, fasting and 2-hr insulin 
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and HbA1c levels results were significantly associated with short sleep, but attenuated after 
adjusting for BMI (21). Knutson and colleagues conducted a small study of African American 
volunteers and demonstrated that both sleep duration and quality were associated with HbA1c 
level (24). If individuals with a recent diagnosis of diabetes are at an increased risk of developing 
chronic sleep disturbances, a known risk factor for poor glycemic control, this offers an area of 
intervention and treatment that might plausibly reduce the individual and societal burden. 
While previous studies have demonstrated the association between sleep duration and 
sleep quality on the development of diabetes, few have determined whether incident diabetes 
increases the odds of developing a sleeping disturbance. Those that do exist had small sample 
sizes and were not able to detect differences by gender (24-26). In our study, we assess the odds 
of developing a chronic sleep disturbance within four years among adults with a recent diagnosis 
of diabetes compared to adults with prevalent diabetes and those without a diagnosis of diabetes. 
We will also assess differences by gender given the higher rates of sleep disturbances typically 
reported in women, the inconclusive results of previous studies assessing the role of gender in 
the relationship between type II diabetes and sleep disturbances, as well as differences in 
inflammatory markers by gender (8, 10, 14, 27). 
Methods 
Participants 
Health and Retirement Study 
Participants were drawn from the Health and Retirement Study. The Health and Retirement 
Study is a national, longitudinal study representative of the U.S. population age 50 and older. 
The study began in 1992 and includes a new cohort of individuals age 50-55 every six years in 
order to maintain representation of the U.S. population in this age group as well as the older age 
groups as the study sample ages (28). Panel participants are interviewed every two years by 
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phone or in person. The complex sample design, including oversamples of Black and Hispanic 
participants, allows for broad population-based inferences (29). The Health and Retirement 
Study is approved by the University of Michigan Institutional Review Board and is sponsored by 
the National Institute on Aging (grant number NIA U01AG009740) and is conducted by the 
University of Michigan. 
Study Sample 
Participants for the current study were selected from those who completed an HRS 
interview in 2010.  Figure 3.1 provides a description of the sample. A total of 19,331 participants 
completed an interview in 2010. Participants who were interviewed by proxy or in a nursing 
home in 2006 were not eligible for inclusion in the study. Participants who missed an interview 
in 2010 or 2014, or were deceased after 2010 were not eligible for inclusion in the study. 
Participants with missing data on key covariates were excluded from the current analysis. Each 
wave of data collection, a random half of participants are selected for in-home anthropometric 
measurements including height and weight. Those who did not have height and weight 
measurements (n=6,784) in 2010 were excluded from the current study given the importance of 
obesity in assessing the relationship between diabetes and sleep disturbances. After exclusion for 
missing data on key covariates (n=196) and those who reported a chronic sleep disturbance at 
baseline (n=4,336), 8,015 participants remained in the sample.  
Measures 
Self-reported measures of demographic characteristics and health status were collected in 
2010 and in 2014.  
Exposure: Diabetes status  
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Diabetes status was categorized as not diabetic, a new case of diabetes or as having 
diabetes for two or more years based on self-report at the time of the interview in 2010 or the 
results of a hemoglobin A1C assay from a dried blood spot sample collected at the time of the 
interview. Participants were considered to be not diabetic if they reported that they had not 
received a medical diagnosis of diabetes and did not have an A1c result of 6.5mg/dL or greater. 
Participants were considered recently diagnosed with diabetes if they first reported a diagnosis 
of diabetes during their 2010 interview and stated that the diagnosis had occurred since 2009 or 
stated that they had not received a diagnosis or diabetes but had an A1c result of 6.5 mg/dl or 
greater. Participants were considered to have diabetes for two or more years if they had 
previously reported a diagnosis of diabetes and confirmed the diagnosis in their current 
interview. 
Outcome: Sleep disturbances 
Participants were asked three questions related to sleep disturbance in 2010 and 2014. 
The questions were: 
How often do you have trouble falling asleep? 
How often do you have trouble with waking up during the night? 
How often do you have trouble with waking up too early and not being able to fall asleep again? 
Three response options were offered for each of the questions: “Would you say most of the time, 
sometimes, or rarely or never?”. 
Several measures of chronic sleep disturbance were created based on the literature. 
Participants were categorized as having trouble falling asleep, an indication of insomnia, if they 
responded “most of the time” to the question. Participants were categorized as having trouble 
staying asleep if they responded “most of the time” to either of the two questions on waking up 
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during the night or waking up too early. Participants were considered to have a chronic sleep 
disturbance if they responded “most of the time” to one or more of the three questions related to 
trouble sleeping.  
Covariates: Demographic, health behaviors, health conditions  
Demographic variables include self-reported age at the time of interview, gender, years of 
education and race/ethnicity. Respondents were categorized as Hispanic, non-Hispanic Black, 
non-Hispanic white/other based on responses to two separate questions on Hispanic ethnicity and 
race. Education level was categorized as less than high school, high school graduate, some 
college or college graduate. Educational level is considered a proxy measure of socio-economic 
status given the age and working status in the study population. Marital status was coded as 
currently married versus not married (including never married, separated/divorced and 
widowed). Work status was coded as currently working or not working.   
Health behaviors of interest included self-reported measures of physical activity, current 
smoking status and current alcohol consumption. Participants who reported engaging in 
moderate or vigorous physical activity at least once a week on average were considered to be 
physically active. Respondents who reported that they were current cigarette smokers were 
categorized as smokers. Current alcohol consumption on two or more days per week was 
considered positive for alcohol consumption. 
Other health conditions that were considered potential confounders or moderators in the 
association between diabetic status and chronic sleep disturbances were included based on self-
report (Has a doctor or other medical professional ever told you that you have…”). Health 
conditions of interest included hypertension, heart disease, heart attack, stroke, lung diseases, 
cancer, emotional, nervous or psychiatric problems, depression, chronic pain, arthritis or urinary 
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incontinence. Body mass index (BMI) was calculated based on self-reported height and weight 
or height and weight measured by an interviewer during the in-home visit. A BMI of 25-29.9 
was considered overweight and a BMI of 30 or greater was considered obese. 
Statistical Analysis 
Cases meeting inclusion criteria at baseline (2010) were merged with interview data 
collected in 2014. Descriptive data analysis of all baseline characteristics was conducted for all 
of the sample as well as with the exposure variables and the outcome variables. Mean values of 
continuous variables were compared using t-tests.  Rao-Scott chi-square tests were utilized to 
assess the bivariate associations of categorical variables. All reported values were weighted for 
the complex survey design and survey non-response. Complex survey procedures were used in 
data analysis to compute 95% confidence intervals to account for the multi-stage cluster sample 
design.  
Logistic regression models were estimated to determine the odds, among those who did 
not report a chronic sleep disturbance at baseline, of developing a chronic sleep disturbance after 
four years among participants without diabetes, participants with a recent diagnosis of diabetes 
and participants with a prior diagnosis of diabetes. Multiple logistic regression models were 
estimated to assess the odds of developing a chronic sleep disturbance given the participant’s 
baseline diabetic status. Regression models were stratified by gender. Three logistic regression 
models were calculated per gender to determine the impact of demographic, behavioral and 
health risk factors on the development of chronic sleep conditions. Model 1 assessed the 
unadjusted odds ratio of developing chronic sleep disturbance by diabetic status. Model 2 
adjusted for demographic characteristics including age, race/ethnicity and education. Model 3 
adjusted for the model 2 variables as well as other lifestyle and health covariates including 
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current employment and marital status, physical activity, alcohol consumption, smoking status, 
obesity, hypertension, heart disease, chronic pain, depression, incontinence and arthritis. 
Comparisons were made between those recently diagnosed with diabetes versus those with a 
prior diagnosis of diabetes, compared to those without a diagnosis of diabetes (reference group). 
First order interactions were assessed among key predictors. Odds ratios and 95% confidence 
intervals were calculated for all covariates in each model. The complex sample design 
characteristics (strata, cluster and respondent weights) were utilized at all stages of analysis.  All 
statistical tests were two-sided at a significance level of .05.  SAS v9.4 (SAS Institute, Inc., Cary, 
NC) was used for data analysis.  
Results 
Weighted estimates of demographic characteristics, health behaviors and health 
conditions of the study population at baseline are shown in Table 3.1. Just over half of the study 
population was female (53.5%) and the average age of the population represented by the eligible 
sample was 61.9 years (range 50-101). Differences were observed between men and women in 
most demographic characteristics. Men in the study population were more likely to be younger, 
non-Hispanic White/Other, have a college degree, and to be currently working as well as married 
(p<0.001 for all observed differences). Additionally men were more likely to report engaging in 
moderate or vigorous physical activity on a weekly basis and consuming alcohol on two or more 
days per week than women. Women were less likely to have newly diagnosed diabetes but more 
likely to report having a previous diagnosis of diabetes prior to 2009. Half the population of men 
and women had hypertension. With the exception of stroke, women reported higher rates of each 
chronic condition than men including arthritis, lung disease, cancer, depression, pain and urinary 
incontinence. The greatest differences were for arthritis (women 51.6%, men 35.6%), depression 
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(women 21.7%, men 11.5%), pain (women 30.1%, men 24.0%) and urinary incontinence 
(women 24.8%, men 7.1%). While the mean BMI was similar for men and women, 29.4 and 
29.0 respectively, women had slightly higher rates of obesity whereas men were more likely to 
be overweight. Differences between gender were statistically significant at p<0.001.  
Women were more likely than men to report chronic sleep disturbances after four years 
for each type of sleep disturbance. Men reported difficulty staying asleep as the most frequent 
sleep disturbance. Among men, those with existing diabetes reported difficulty staying asleep 
slightly more often than those who were newly diagnosed with diabetes. However, men with 
newly diagnosed diabetes were more likely than those without diabetes and those with existing 
diabetes to report one or more chronic sleep disturbance after four years (19.3 vs 16.7 vs 17.1, 
respectively). These differences were not statistically significant for men. Close to one-third of 
women with newly diagnosed diabetes reported the development of a chronic sleep disturbance 
after four years. In women, the prevalence of chronic sleep disturbances were 37% higher in 
those with newly diagnosed diabetes than those with existing diabetes, and 56% greater than 
those without diabetes. Women with newly diagnosed diabetes were more than twice as likely as 
those without diabetes to report chronic difficulty falling asleep (18.4% vs 8.1%). However, 
these differences were not statistically significant within women.  
The odds of developing a chronic sleep disturbance within four years are shown in Table 
3.3. Men with recently diagnosed diabetes were 19% more likely to develop a chronic sleep 
disturbance within four years than those without diabetes (OR 1.19; 95% CI 0.71-1.99). 
However, this result was not significant and was slightly attenuated after adjustment for 
demographic and lifestyle covariates as well as health conditions which included obesity, 
hypertension, chronic pain, arthritis, ever had depression and incontinence (OR 1.14; 95% CI 
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0.69-1.90). In the fully adjusted model for men, those who reported that they were currently 
working at the time of the baseline interview were 25% less likely to develop a chronic sleep 
disturbance within four years (OR 0.75; 95% CI 0.60-0.95). However, in the fully adjusted 
model, men who reported experiencing chronic pain or ever experiencing a depressive episode 
were more likely to develop a chronic sleep disturbance within four years than those without 
pain or depression (pain OR 1.39, 95%CI 1.04-1.85; depression OR 1.56, 95%CI 1.08-2.26). 
These results are shown in supplemental table 4.1 In the unadjusted model, women with recently 
diagnosed diabetes were 80% more likely to develop a chronic sleep disturbance within four 
years than those without diabetes (OR 1.80; 95% CI 1.01-3.20). Although the direction of the 
association was maintained, the association was attenuated after adjustment for demographic and 
lifestyle covariates as well as chronic health conditions (OR 1.63; 95%CI 0.86-3.09).  
In the fully adjusted model for women, being 70 years of age or older, Black, and 
currently working were all protective against the development of a chronic sleep disturbance 
after four years. Those between the ages of 70 to 79 were 30% less likely to develop a chronic 
sleep disturbance and those who were 80 years or older at baseline were 41% less likely than 
women between the ages of 50 to 59 to develop a chronic sleep disturbance. Non-Hispanic Black 
women were 23% less likely to develop a chronic sleep disturbance after four years than non-
Hispanic white women (OR 0.77; 95%CI 0.60-0.98). Women who reported that they were 
currently working during their baseline interview were 31% less likely to develop a chronic sleep 
disturbance than those who were not working at that time (OR 0.68; 95% CI 0.53-0.87). 
However, women with other chronic conditions, including pain, depression, incontinence and 
arthritis, were significantly more likely to report chronic sleep disturbances after four years 
(supplemental table 4.1). First-order interactions between diabetes status and pain, depression, 
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incontinence and arthritis were assessed in the fully adjusted models for men and women. The 
interaction terms were not statistically significant.  
Discussion 
In this population-based study of community-dwelling older men and women, we find 
that women report higher rates of chronic sleep disturbances than men and that those with a 
recent diagnosis of diabetes report higher rates of chronic sleep disturbances after four years than 
those without diabetes. Close to thirty-percent of women with newly diagnosed type II diabetes 
and twenty-percent of men reported the development of a chronic sleep disturbance within four 
years of receiving a diagnosis of diabetes. Among the initial study population, 47.5% of women 
and 33.5% of men with a recent diagnosis of diabetes reported having one or more chronic sleep 
disturbances at baseline. While these individuals were excluded from the current study, this 
indicates that over 75% of women and over 50% of men will have experienced a chronic sleep 
disturbance at the time of diagnosis or within four years of receiving a diagnosis of diabetes. 
Given the effects of chronic sleep disturbances on glycemic control, this is a grave concern. 
Women with recently diagnosed diabetes had an 80% greater (unadjusted) odds of 
developing a chronic sleep disturbance within four years than those without diabetes. The odds 
decreased to 18% for those with longer-term type II diabetes indicating that the development of a 
new chronic sleep disorder may be most likely to occur within a few years of diagnosis. While 
the association was attenuated in women after controlling for demographic characteristics, 
behavioral factors and health conditions, the magnitude of the association continued to indicate 
the increased odds of developing a chronic sleep condition in women with a recent diagnosis of 
diabetes. Women aged 70 and older at the time of diagnosis as well as non-Hispanic Black 
women appear to have a decreased risk of developing a chronic sleep disturbance. However, the 
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contribution of other chronic conditions to the development of a chronic sleep disturbance cannot 
be overlooked. While the associations in men are not significant, the role of pain and depression 
in the development of chronic sleep disturbances is observed as well. The results in both women 
and men provide support for the potential pathways of the psychosocial impact of a new 
diagnosis, nocturia and inflammation in the development of chronic sleep disturbances among 
those recently diagnosed with diabetes.  
While previous studies have found that chronic sleep disturbances appear to precede or 
coincide with the diagnosis of diabetes, the results of this study show that the development of 
chronic sleep disturbances continues to be of clinical importance among older adults with a new 
diagnosis of diabetes, and potentially to a greater degree among women than men. The potential 
mechanisms leading to the differences in this association between men and women must be 
considered, including differences in hormonal, psychosocial and environmental conditions as 
well as the impact of the comorbidity of chronic sleep disturbances and diabetes with other 
existing conditions such as chronic pain, depression and anxiety and arthritis. Previous studies 
have primarily focused on sleep duration, rather than sleep quality. To our knowledge, this is the 
first study to examine the association between sleep quality and incident diabetes, rather than 
prevalent diabetes.  
This study has numerous strengths including the large, nationally representative sample 
and the longitudinal study design. Additionally, this study provides information on sleep quality 
and adds to the growing body of literature on the importance of sleep quality in addition to the 
impact of sleep duration. The greatest limitation of the current study is that both the exposure 
and outcome are based on self-report. The use of hemoglobin A1c results to categorize diabetics 
increased the diagnosis of incident diabetics by 33%. However, hemoglobin A1c was only 
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measured in a random half of the population. Thus, we might estimate that approximately 80 
additional individuals with undiagnosed diabetes exist in our study population. Additionally, 
measures of sleep quality were collected at baseline and after four years. While a goal of the 
current study was to assess the development of chronic sleep disturbances, rather than transient 
disturbances occurring shortly after the diagnosis, it is possible that our results under estimate the 
magnitude of sleep disturbances given the time lapse in assessment. The incorporation of 
clinically validated measures of sleep disturbance, such as actigraphy, may help increase the 
sensitivity of the measurement of sleep disturbances as compared to self-reported measures of 
sleep quality. Additionally, we cannot rule out the role of sleep apnea in the current association 
or other unmeasured confounders.  
Current assessment and treatment guidelines for individuals recently diagnosed with 
diabetes do not include the assessment of sleep disturbances. Given the negative repercussions of 
untreated chronic sleep disturbances on glycemic control, chronic sleep conditions should be 
assessed at follow-up visits as well as initial visits.  Such discussions are especially important 
among individuals with multiple chronic conditions as they appear to be at increased risk of 
developing chronic sleep disturbances. Incorporating discussions on sleep hygiene, as well as 
detecting the need for pharmacological treatment of chronic sleep disturbances, should be a 
standard of care among those treating individuals with type II diabetes. 
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Figure 3.1 Study population 
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  Men Women All 
  n=3075 n= 4288 n= 8015 
Demographic Characteristics % (SE) % (SE) % (SE) 
Age (mean yrs, SE) 61.1 (0.3) 62.7 (0.3) 61.9 (0.3) 
Age categories*    
   50-59 years 55.4 (1.6) 48.4 (1.6) 51.9 (1.5) 
   60-69 years 26.3 (1.1) 28.0 (1.1) 27.1 (0.9) 
   70-79 years 12.3 (0.8) 14.1 (0.7) 13.2 (0.7) 
   80 or older 6.0 (0.5) 9.5 (0.6) 7.8 (0.5) 
Race/Ethnicity*    
   White/other, non-Hispanic 80.2 (1.6) 78.0 (1.6) 79.1 (1.5) 
   Black, non-Hispanic 10.6 (0.8) 13.1 (1.1) 11.8 (0.9) 
   Hispanic 9.2 (1.4) 8.9 (1.4) 9.1 (1.4) 
Education*    
      < High School 14.1 (0.9) 12.9 (1.0) 13.5 (0.9) 
      High School 26.4 (1.0) 31.6 (1.1) 29.0 (0.8) 
      Some College 25.6 (1.1) 26.8 (1.0) 26.2 (0.9) 
      College degree  33.9 (1.4) 28.7 (1.2) 31.3 (1.0) 
Currently married* 70.6 (1.2) 56.6 (1.0) 63.6 (0.9) 
Currently working* 57.3 (1.3) 49.2 (1.3) 53.2 (1.2) 
Health Behaviors    
   Weekly moderate or vigorous phys activity* 74.3 (0.9) 67.2 (1.1) 70.7 (1.9) 
   Current smoker** 17.6 (0.8) 14.4 (0.7) 16.0 (0.6) 
   Alcohol use >= 2d/wk* 36.5 (1.2) 22.8 (1.0) 29.6 (3.1) 
Health Conditions    
   Diabetes status*    
     Recently diagnosed (2009 or later) 5.3 (0.6) 2.9 (0.4) 4.1 (0.4) 
     Diabetes since 2008 or earlier 14.1 (0.6) 15.8 (0.7) 15.0 (0.5) 
   Hypertension 50.0 (1.1) 50.1 (1.2) 50.1 (0.8) 
   Heart disease** 18.0 (0.7) 14.9 (0.8) 16.5 (0.5) 
   Stroke 4.4 (0.4) 3.7 (0.4) 4.0 (0.3) 
   Arthritis* 35.6 (1.2) 51.6 (0.9) 43.7 (0.9) 
   Lung disease 6.0 (0.5) 7.1 (0.5) 6.6 (0.4) 
   Cancer*** 10.0 (0.6) 11.7 (0.6) 10.9 (0.5) 
   Emotional/psychiatric problem* 9.5 (0.7) 17.0 (0.8) 13.3 (0.5) 
   Depression (ever)* 11.5 (0.7) 21.7 (0.9) 16.6 (0.5) 
   Pain* 24.0 (0.9) 30.1 (0.9) 27.1 (0.7) 
   Urinary incontinence* 7.1 (0.5) 24.8 (1.1) 16.0 (0.7) 
   BMI (mean, SE) 29.4 (0.1) 29.0 (0.1) 29.2 (0.9) 
      Overweight* 43.7 (1.0) 30.7 (0.9) 37.2 (0.6) 
      Obese 36.9 (0.9) 38.2 (0.9) 37.6 (0.7) 
Percentages and standard errors weighted for complex sample design. Differences between gender 
assessed by Rao-Scott chi-square test for categorical variables and t-tests for continuous variables. 
*p<0.001; ** p<0.01, ***p<0.05. 
Table 3.1 Baseline characteristics of the study population by gender. 
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 Men (n=3727)   Women (n=4288) 
 No Diabetes New diabetes Diabetes 2+ years  No Diabetes New diabetes 
Diabetes 2+ 
years 
 n=2888 n=177 n=662  n=3371 n=145 n=772 
 % (SE) % (SE) % (SE)   % (SE) % (SE) % (SE) 
Trouble Most of the Time        
   Falling Asleep 5.4 (0.5) 8.6 (3.5) 6.3 (1.0)  8.1 (0.6) 18.4 (5.8) 9.8 (1.3) 
   Staying Asleep 14.8 (1.0) 15.3 (3.6) 15.6 (1.8)  15.3 (0.8) 19.5 (4.5) 19.2 (1.8) 
   One or More Chronic Sleep Disturbance 16.7 (1.0) 19.3 (3.9) 17.1 (1.7)   18.6 (0.9) 29.1 (5.7) 21.3 (1.9) 
Diabetes based on self-report of having received a diagnosis from a medical professional or HbA1c >6.5mg/dl. 
No diabetes: no diagnosis and HbA1c<6.5; New diabetes: Self-report of diagnosis in 2009 or later or HbA1c in 2010 >6.5mg/dl; Diabetes 2+ years: Self-report 
of diagnosis prior to 2009. 
Sleep disturbances reported in 2014 interview: trouble falling asleep, trouble waking up and not falling back asleep, trouble waking up too early. 
Percentages and standard errors weighted for complex sample design. *Rao-Scott Chi-square test of significance within gender, p<0.05. 
 
 
 
Table 3.2. Development of chronic sleep disturbances within 4 years by gender and diabetic status at baseline.    
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  Men Women      
  OR (95% CI)  OR (95% CI)      
Logistic Regression Models        
   Unadjusted 1.19 (0.71-1.99) 1.80 (1.01-3.20)      
   Adjusted-1 1.21 (0.71-2.04) 1.77 (0.98-3.20)      
   Adjusted-2 1.16 (0.69-1.90) 1.63 (0.86-3.09)      
Model Adjusted-1: adjusted for demographic characteristics age, education, race/ethnicity,  
and prevalent diabetes. 
Model Adjusted-2: adjusted for model 1 variables plus lifestyle and health variables including marital status,  
employment status, physical activity, smoking, alcohol consumption, obesity, hypertension, chronic pain, 
arthritis,  
ever had depression, incontinence. 
 
Table 3.3 Odds of developing a chronic sleep disturbances within four years of being diagnosed with diabetes. 
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Supplemental Table 3.1s. Logistic regression models of the odds of developing a chronic sleep disturbance within 4 years by baseline diabetic status and 
gender. 
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Chapter 4  Comorbidity of diabetes and chronic sleep disturbances and consumption of a 
Mediterranean-style diet. 
Abstract 
Objective: This study assessed whether comorbidity of diabetes and chronic sleep disturbances 
was associated with less healthy dietary consumption, defined as a Mediterranean-style Diet, 
compared to adults with only one or neither of the conditions.   
Research Design and Methods: Participants were selected from the Health and Retirement 
Study (HRS). Diabetes status and chronic sleep disturbances were assessed during the 2010 
interview. Participants were categorized into one of four groups: no sleep disturbances or 
diabetes, sleep disturbances, diabetes, or sleep disturbances and diabetes. In 2013, 7,423 
participants completed a food frequency questionnaire by mail from which the alternative 
Mediterranean Diet (aMedDiet) score was calculated. Logistic regression was used to assess the 
main effects of chronic sleep disturbances and diabetes on aMedDiet as well as the interaction of 
chronic sleep disturbances and diabetes on dietary intake. The odds of consuming an aMedDiet 
in the highest versus the lowest quartile was estimated based on comorbidity of diabetes and 
chronic sleep disturbances. Models were stratified by gender. A sensitivity analysis was 
conducted to assess the linear relationship between diabetes status, chronic sleep disturbances 
and the aMedDiet score among the full study population. 
Results: After adjusting for age and caloric intake, men with diabetes were more likely to 
consume an aMedDiet in the highest quartile (OR 1.45; 95% CI 1.11-1.91) than men with neither 
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chronic sleep disturbances nor diabetes. The magnitude of the association increased after 
adjustment for additional demographic and health variables (OR 1.70, 95% CI 1.25-2.29). 
Women with sleep disturbances were less likely to consume an aMedDiet than those without 
sleep disturbances. The reduction in the odds of consuming an aMedDiet was greatest among 
women with comorbidity of the two conditions (OR 0.53, 95% CI 0.37-0.77) yet was also 
significant among those with chronic sleep disturbances alone (OR sleep disturbances 0.71, 95% 
CI 0.56-0.90). The results in women were attenuated after multivariate adjustment. The direction 
of the associations was the same using linear regression. 
Conclusion: Chronic sleep disturbances are associated with reduced healthy dietary intake in 
adults with diabetes. Differences in the association between diabetes and dietary intake are 
observed between men and women, as well as in the joint association of diabetes and chronic 
sleep disturbances and dietary intake. 
Key words cohort, sleep disturbance, sleep quality, diabetes, dietary intake, nutrition, 
Mediterranean Diet, comorbidity 
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Introduction 
The prevalence of diagnosed diabetes among adults in the United States nearly tripled 
between 2008 and 2012 with the greatest increases among women, those with a high school 
education, older adults and Hispanic adults (1-3). The increase in type II diabetes brings with it 
additional population-based and individual costs and considerations. At the individual level, 
access to adequate and routine medical care, access to affordable medication and the ability to 
maintain one’s employment and lifestyle are all important. At the population-level, the increased 
prevalence of diabetes can lead to an increased population burden related to medical care and 
prescription coverage among the un- and under-insured, lost days of work and productivity, as 
well as increased demands on caregivers. 
Glycemic control is the primary goal of individuals with diabetes. This is accomplished 
through a combination of healthy lifestyle choices as well as medication. A key component of a 
healthy lifestyle is consuming a diet that provides food sources and nutrients that maintain 
glycemic control. The Mediterranean diet has been identified as a plant-based dietary pattern that 
is associated with healthy aging, improved glycemic control and reduced insulin resistance in 
healthy populations, as well as in those with cardiovascular disease including hypertension and 
diabetes (4-5). Plant-based diets that are naturally high in polyphenols and low in saturated fats 
are also associated with decreased inflammation (6-9). Recent evidence also supports the role of 
the Mediterranean Diet in improving the gut microbiome thereby reducing inflammation and 
potentially improving glycemic control as well (10,11). The Mediterranean diet is considered a 
healthy diet for those with diabetes and meets the key dietary criteria outlined by the American 
Diabetes Association as it is naturally low in saturated fats, highly processed foods and refined 
carbohydrates.  
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Chronic sleep deprivation, as well as poor sleep quality, has been linked to metabolic 
disturbances, including increased caloric intake and cravings for refined carbohydrates (12,13). 
While such metabolic disturbances are not healthy for the population in general, these 
disturbances can lead to deleterious outcomes among individuals with diabetes whose daily goal 
is to maintain glycemic control. Numerous studies have shown an increased prevalence of sleep 
disruptions among individuals with diabetes (14-24). However, little is known about the 
association between chronic sleep disturbances and dietary intake specifically among adults with 
diabetes.  Given the importance of a healthy dietary intake among those with diabetes, a better 
understanding of this potential relationship could allow for improved care and treatment, thus 
improving the quality of life and potential outcomes of adults with diabetes. 
The goals of this study were to determine whether older adults with diabetes and chronic 
sleep disturbances were less likely to consume a healthy diet, as measured by the alternate 
Mediterranean Diet score, than those without diabetes or chronic sleep disturbances. Differences 
in the association were assessed by gender as well as race and ethnicity given the increased rates 
of chronic sleep disturbances among women compared to men and increased rates of diabetes 
among Black and Hispanic adults. 
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Research Design and Methods 
Participants were drawn from the Health and Retirement Study. The Health and Retirement 
Study is a national, longitudinal study representative of the U.S. population age 51 and older. 
The study began in 1992 and includes a new cohort of individuals age 50-55 every six years in 
order to maintain representation of the U.S. population in this age group as well as the older age 
groups as the study sample ages. The study is designed to measure the health and wealth of the 
U.S. population pre-retirement and as the population ages and retires. The study has been 
described in detail previously (25). Panel participants are interviewed every two years by phone 
or in person. The complex sample design, including oversamples of Black and Hispanic 
participants, allows for broad population-based inferences (26). The Health and Retirement 
Study is approved by the University of Michigan Institutional Review Board. The Health and 
Retirement Study (HRS) is sponsored by the National Institute on Aging (grant number NIA 
U01AG009740) and is conducted by the University of Michigan. The NIA provided funding for 
the 2013 HCNS as well (27). 
Study Sample 
Participants for the current study were those that completed an interview for the Health 
and Retirement Study (HRS) in 2010 as well as the Health Care and Nutrition Study (HCNS) in 
2013 (n=8,035). The HCNS was a self-administered survey mailed to a subset of HRS panel 
participants and included questions on health care access and utilization, food security and 
availability as well as a previously validated Food Frequency Questionnaire (FFQ) (28-30). 
Those who reported daily caloric intake levels, calculated from the HCNS FFQ, above or below 
extreme values were excluded (<500 or >8000 calories/day; n=342).  Cases were excluded if 
they did not provide a response to questions on sleep disturbances (n=342) during their 2010 
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interview. A total of 7,423 participants (4,429 women, 2,994 men) were included in the current 
study ranging in age from 52-96 years.  
Measures 
Self-reported measures of demographic characteristics and health status, including sleep 
quality measures and diabetic status, were collected at each two-year period.  
Chronic sleep disturbances  
Participants were asked three questions related to the frequency of sleep disturbances. 
The questions assessed difficulty initiating and maintaining sleep. The questions were: “How 
often do you have trouble falling asleep?”, “How often do you have trouble with waking up 
during the night?” and “How often do you have trouble with waking up too early and not being 
able to fall asleep again?”.  Three response options were read aloud to the participant: Most of 
the time, Sometimes, Rarely or Never. Responses to the three questions were dichotomized to 
1=Yes (Most of the time) or 0=No (Sometimes, rarely or never) in order to capture ongoing, 
chronic sleep disturbances. The number of sleep disturbance problems endorsed was calculated 
by summing the response to these three questions. A composite variable was created to 
categorize those who reported that they had one or more chronic sleep disturbance most of the 
time versus those who did not have a chronic sleep disturbance.  
Diabetes 
A participant was considered as having diabetes if they reported that a doctor or other 
medical professional had told them that they had diabetes during their 2012 interview or prior. 
Hemoglobin A1C values from the two most recent interviews (2010 and 2012) were evaluated 
for participants who reported that they had never been diagnosed with diabetes. A result of 
6.5mg/dL or greater, assayed from a non-fasting dried blood spot collected in the home at the 
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time of the interview was considered positive for diabetes (1). Collection and processing 
procedures for the dried blood spots have been described previously (30). 
Comorbid diabetes and chronic sleep disturbances 
Respondents were categorized into 4 groups to determine the comorbidity of diabetes and 
chronic sleep disturbances: 1) those who did not report either chronic sleep conditions or a 
diagnosis of diabetes, 2) those who reported chronic sleep disturbances but no diagnosis of 
diabetes, 3) those who did not report a chronic sleep disturbance but had been previously told by 
a doctor or other health care professional that they had diabetes and, 4) those who reported both a 
chronic sleep disturbance and a previous diagnosis of diabetes. Both self-reported diabetes and a 
HgA1c >6.5mg/dL were considered to be positive for diabetes. 
Mediterranean Diet Score 
Mediterranean Diet intake was determined using dietary intake information from the food 
frequency questionnaire (FFQ) included in the 2013 HCNS. The FFQ was previously validated 
as the Harvard Food Frequency Questionnaire (28-30). The Alternate Mediterranean Diet score 
(aMedDiet)was calculated (4, 31). The aMedDiet includes 9 components, each scored 0 or 1. The 
scores are summed with the total aMedDiet score ranging from 0 to 9, with 0 representing the 
lowest consumption and 9 the highest consumption of a Mediterranean Diet. The aMedDiet score 
was calculated both by assessing gender-specific median values of daily fruit, vegetable, whole-
grain, red/processed meats, alcohol, nuts, legumes, fish and the ratio of monounsaturated fats to 
saturated fats as well as a score for the full study population. A score of 1 is given to intake 
values above the gender-specific median for all items with the exception of alcohol and red meat 
consumption. One point is given for moderate alcohol intake (.5-1.5 drinks per day for women, 
.5-2 drinks per day for men). Less than moderate alcohol consumption  is scored zero. 
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Consumption below the median intake value for red meat is scored 1 whereas intake daily 
consumption of red or processed meats at the median level or higher is scored 0, thus 
recognizing the health risks associated with the intake of red and processed meats. Intake of 
potatoes, poultry and full-fat dairy are excluded from the aMedDiet, all of which were included 
in previous Mediterranean Diet scores.  A ratio of healthy to unhealthy fat intake is assessed in 
the aMedDiet whereas the original Mediterranean Diet score included olive oil intake. The 
dietary components and scoring mechanisms for the current study population are shown in 
supplemental table 1.  
Covariates: Demographic, health behaviors, health conditions  
Demographic variables assessed included self-reported age, gender, years of education, 
race and ethnicity. Respondents were categorized as Hispanic, non-Hispanic Black, and non-
Hispanic white/other based on responses to two separate questions on Hispanic ethnicity and 
race. Years of education was used as a measure of socio-economic status and was categorized as 
less than high school, high school graduate, some college and college graduate. Marital and 
employment status were assessed in 2010 and coded as dichotomous variables. Marital status 
was coded as currently married versus not married (including never married, separated/divorced 
and widowed). Work status was coded as currently working or not working.  
Health behaviors of interest included self-reported measures of physical activity and 
current smoking status. Participants who reported engaging in moderate or vigorous physical 
activity at least once a week on average were considered to be physically active. Respondents 
who reported that they currently smoke cigarettes were categorized as smokers.  
Respondents were asked about the presence of chronic diseases at the time of the 
interview (“Has a doctor or other medical professional ever told you that you have…”). Self-
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reported previous diagnosis of hypertension, heart disease, previous heart attack and depression 
were dichotomized based on either having the condition or not having the condition. Body mass 
index (BMI) was calculated based on self-reported height and weight in 2010. For those 
respondents who did not provide their height or weight in 2010, current height and weight were 
imputed from the previous interview. A correction factor was applied to weight based on the 
mean weight increase in the two years. Weight was recorded in pounds to the nearest half pound. 
Height was measured in inches to the nearest half inch. Body mass index was calculated as 
(weight/ height2) x 703. BMI was then categorized as normal weight (up to 24.9), overweight 
(25-29.9) and obese (30 or greater) (33). 
Statistical Analysis 
A descriptive analysis of all demographic, health behaviors and conditions was assessed 
by gender, as well as by the exposure and the outcome. Mean values of continuous variables 
were compared using analysis of variance.  Chi-square tests were utilized to assess the 
associations of categorical variables. The mean Mediterranean diet score was assessed by gender 
and comorbidity of chronic sleep disturbances and diabetes. Dietary intake scores for each of the 
nine Mediterranean Diet components were assessed by gender and both the main effects of 
chronic sleep disturbances and diabetes, as well as the comorbidity of both chronic sleep 
disturbances and diabetes, to determine the foods with the greatest difference in intake between 
subgroups. Gender-specific quartiles of Mediterranean Diet intake were created based on the 
aMedDiet score. Logistic regression was used to assess the odds of consuming a Mediterranean 
diet by comparing the highest intake quartile with the lowest. In women, a score of 2 or lower 
was categorized as the lowest quartile and a score of 6 or higher was considered the highest 
intake quartile. In men, the lowest quartile was based on a score of 3 or less. The highest quartile 
 86 
of intake for men was the same as the cut-off for women (6-9). Separate models were calculated 
by gender to assess the odds of consuming a high aMedDiet in the presence or absence of 
chronic sleep disturbances and diabetes (four groups of comorbidity of the two conditions 
described previously). First, the main effects of diabetes and chronic sleep disturbances were 
assessed in separate multivariate logistic regression models. Next, the joint association of chronic 
sleep disturbances and diabetes was assessed by first adjusting for age and caloric intake as well 
as the complex sample design. Additional multivariate logistic regression models were estimated 
adjusting for age, caloric intake, demographic, behavior and health characteristics including 
race/ethnicity, education, employment status, marital status, hypertension, depression, smoking, 
physical activity and obesity (categorized as normal weight, overweight or obese). As a 
sensitivity analysis, the aMedDiet score was calculated for the full study population and 
multivariate linear regression was used to assess the relationship between diabetes and chronic 
sleep disturbances with the score as the outcome variable. All analyses were weighted for the 
complex sample design. All statistical tests were two-sided at a significance level of 0.05. SAS 
v9.4 (SAS Institute, Inc., Cary, NC) was used for data analysis.  
Results 
Demographic, lifestyle and health characteristics of the study population are shown in 
supplemental table 4.S1. The mean age of the population was 65 years of age (65.2 men, 64.9 
women). Close to one-third of men and women reported suffering from a chronic sleep 
disturbance (31.3% of men and 35.2% of women, p=0.001). The most common sleep disturbance 
for both genders was waking up at night and not being able to fall back asleep. Approximately a 
quarter of men and women had previously been told by a doctor that they had diabetes or had an 
HbA1c result indicative of diabetes (26.7% men, 24.2% women, p=0.015).  In assessing the 
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comorbidity of diabetes and chronic sleep disturbances, just over half of all men and women did 
not report the presence of chronic sleep disturbances or diabetes (51%). Slightly more women 
than men had sleep disturbances but not diabetes (25.0% vs 22.3%, respectively).  The presence 
of diabetes without a chronic sleep disturbance was more common in men than women (17.7% 
vs. 13.9%, respectively). Women were more likely to have both chronic sleep disturbances and 
diabetes than men (10.2% vs. 9.0%, respectively). The differences by gender were statistically 
significant (p<0.001). The average Mediterranean Diet score was 4.0 in men and 3.9 in women 
and ranged from 0 to 9 in both men and women. Total daily caloric intake was higher in men 
than women (2013 vs. 1797 kcal/day, p<0.001). 
In men, the average aMedDiet score was highest in those with diabetes and no sleep 
disturbances (4.24±1.88). In women, the aMedDiet was highest among those without sleep 
disturbances or diabetes (4.06±2.09). The aMedDiet score was lower among those with chronic 
sleep disturbances than among those without sleep disturbances and those without diabetes for 
both men and women. The cormorbidity group with the lowest average aMedDiet score in both 
men and women was the group with both chronic sleep disturbances and diabetes (men: 
3.87±1.90; women: 3.63±1.82). Differences within and between gender were statistically 
significant (shown in Figure 4.1a). A similar pattern was observed by gender and comorbid 
group when the full study population score was used. Median scores were slightly higher for all 
components but the increased aMedDiet among men with diabetes was observed whereas women 
without diabetes or chronic sleep disturbances had the highest aMedDiet score. The median 
aMedDiet score was lowest for women with diabetes and chronic sleep disturbances and for men 
who either had chronic sleep disturbances alone or reported chronic sleep disturbances as well as 
diabetes (Figure 4.1b).  
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Variation in consumption of the nine aMedDiet components by comorbidity group was 
observed in men and women. Men with diabetes and sleep disturbances were less likely to 
consume daily servings above the median (i.e. receive a score of 1 for the component) of fruits, 
vegetables, whole grains, nuts and fish than those with diabetes and no sleep disturbances. Men 
with diabetes and sleep disturbances were also more likely to consume higher quantities of 
red/processed meats, less likely to consume moderate alcohol intake, and had a lower 
MUFA:SFA ratio. A similar pattern is observed in women with the exception of consumption of 
alcohol, nuts and fish which is higher among diabetics with sleep disturbances and diabetes than 
those without sleep disturbances. In both men and women, the two groups with chronic sleep 
disturbances have lower intake of the aMedDiet components than those without chronic sleep 
disturbances (table 4.1). 
Significant differences in demographic and health characteristics for those in the highest 
versus the lowest quartile of aMedDiet score were observed by gender (table 4.2). Men in the 
highest quartile of intake were more likely to be Hispanic, have a college degree, be currently 
working, engage in weekly physical activity and not smoke. Men in the highest quartile were 
also less likely to have a chronic sleep disturbance, with or without diabetes, than those in the 
lowest quartile of intake. The differences among women in the highest quartile varied with those 
in the lowest quartile to an even greater degree as significant differences in self-reported health 
conditions were observed as well. In both men and women, those in the highest quartile of 
aMedDiet intake consumed significantly more calories on a daily basis than those in the lowest 
quartile.  
The main effects of diabetes and chronic sleep disturbances were assessed using 
multivariate logistic regression by gender. Men with diabetes alone were more likely to consume 
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an aMedDiet in the highest quartile compared to those without diabetes (OR 1.30, 95% CI 0.95-
1.77) whereas men with chronic sleep disturbances were less likely to consume an aMedDiet in 
the highest quartile (OR 0.84, 95% CI 0.62-1.14). Women with diabetes were just as likely as 
those without diabetes to consume an aMedDiet in the highest quartile (OR 1.00, 95% CI 0.66-
1.50) whereas those with chronic sleep disturbances were less likely to consume an aMedDiet in 
the highest quartile (OR 0.86, 95% CI 0.67-1.09). The main effects were not statistically 
significant (data not shown). 
After adjusting for age and caloric intake, men with diabetes but no chronic sleep 
disturbances were 45% more likely to be in the highest quartile of aMedDiet intake than those 
without diabetes or chronic sleep disturbances (OR 1.45, 95% CI 1.11-1.91). However, although 
not statistically significant, those with sleep disturbances were less likely than those without to 
be in the highest quartile of aMedDiet intake. After multivariate adjustment, the association 
between diabetes and consumption of an aMedDiet was increased (OR 1.70, 95% CI 1.25-2.29). 
The odds of being in the highest quartile of aMedDiet intake was similar for those with sleep 
disturbances, either with or without diabetes, as compared to those without chronic disturbances 
of sleep or diabetes. A somewhat different pattern was observed in women. After adjusting for 
age and caloric intake in women, women with sleep disturbances, with or without diabetes, were 
significantly less likely to be in the highest quartile of aMedDiet intake than those without either 
chronic sleep disturbances or diabetes. Women with sleep disturbances alone were 71% less 
likely to consume an aMedDiet (OR 0.71, 95% CI 0.56-0.90) whereas those with both diabetes 
and chronic sleep disturbances were 53% less likely to be in the highest quartile of aMedDiet 
intake compared to those with neither chronic sleep disturbances nor diabetes (OR 0.53, 95% CI 
0.37-0.77). These results were no longer significant after multivariate adjustment (Table 4.3).  
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The weighted median values used for creating the gender-specific scores and full study 
population score is shown in supplemental table 4.S2. When assessing the relationship between 
diabetes and chronic sleep disturbances as a sensitivity analysis in the full study population using 
multivariate linear regression, those with diabetes and no sleep disturbances have a 0.22 
increased aMedDiet score (95% CI 0.06, 0.37) whereas those with both diabetes and chronic 
sleep disturbances have a -0.14 decreased aMedDiet score (95% CI -0.25, -0.03).  
Conclusions 
The results of our study indicate that men with diabetes are more likely to consume a 
healthy diet, as assessed by the alternate Mediterranean Diet, unless they also have a chronic 
sleep condition. Conversely, we found that women with diabetes are less likely to consume a 
healthy diet, especially in the presence of chronic sleep disturbances. Chronic sleep disturbances 
appear to diminish the association between diabetes and healthy dietary intake. Our study 
provides new evidence that chronic sleep disturbances may be antagonistic, or have a negative 
association, with healthy dietary consumption in adults with diabetes. This finding is of both 
public health and clinical importance given that our study population consisted of individuals 
with a chronic condition, diabetes, for whom a healthy diet is of vital importance.  
The differences by gender may be attributed to differences in the foods men and women 
consume when affected by chronic sleep disturbances. Individuals with chronic sleep 
disturbances tend to exchange consumption of healthier dietary components, such as vegetables 
and lean proteins, for those offering less healthy benefits, such as carbohydrates (33, 34). In our 
study population, women with diabetes reported higher levels of consumption of fruits, whole 
grains and red/processed meats than women with neither diabetes nor chronic sleep disturbances. 
Women with diabetes consumed less vegetables, nuts, legumes, fish and moderate alcohol. 
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Conversely, men with diabetes consumed the highest rates of all aMedDiet food groups with the 
exception of red/processed meats and moderate alcohol consumption. Thus, men with diabetes 
consumed a diet more typical of a Mediterranean diet than women. Additionally, greater declines 
in consumption rates were reported in women with sleep disturbances compared to those with 
neither sleep disturbances nor diabetes, than in men. In our study population, men with diabetes 
consumed fewer calories per day compared to those without diabetes or chronic sleep problems. 
In women, no difference in caloric intake was observed among women with or without diabetes. 
Thus, it appears that women may not adjust their diet in the same way as men with diabetes. 
Differences in treatment and adherence by gender can be considered as possible explanations for 
our findings (35-37). In terms of treatment, it is possible that men are more likely to receive 
nutritional counseling than women, potentially due to gender stereotypes surrounding who plans, 
shops for and prepares meals. Conversely, it is also possible that there are differences in 
perceived treatment with women being more likely to rely on the benefits of pharmaceutical 
treatment rather than changing lifestyle factors that they can influence. A review of behavioral 
factors related to glycemic control among adults with diabetes found that adherence to dietary 
requirements was correlated with increased self-efficacy and coping skills (38). If women with 
diabetes experience lower levels of self-efficacy than men with diabetes, possibly feeling less in 
control of their disease, adherence to dietary intake guidelines could be affected. Halali and 
colleagues found that situational barriers and difficulty resisting temptation, as well as stress-
related eating disorders were the two primary factors that affected dietary adherence in diabetic 
patients (39). While prior studies on dietary adherence among adults with diabetes were not able 
to determine differences by gender, it is possible that these barriers exist to a greater degree in 
women than men. The role of obesity should be considered as well. Obesity may be a confounder 
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as well as a mediator in the relationship between sleep and diet. In our study population, mean 
BMI increased in a linear direction for men and women based on comorbidity of diabetes and 
chronic sleep disturbances. In women, the mean BMI was the same in women with diabetes, with 
or without sleep disturbances, and the difference with those without chronic conditions is greater 
in women than among men. Additionally, both men and women with diabetes and sleep 
disturbances are more likely to be obese. Interaction terms for comorbidity and obesity as well as 
race-ethnicity and obesity were tested in our regression models. While the terms were not 
significant for women, obesity appears to confound the relationship between comorbidity status 
and dietary adherence in men. 
The prevalence of chronic sleep disturbances in our study population is similar to that 
reported in other population-based studies with approximately one-third of women and men 
reporting chronic sleep disturbances. However, these rates were higher among adults with 
diabetes than those without diabetes, with women disproportionately affected by chronic sleep 
disturbances: 30% of men without diabetes and 34% of men with diabetes reported chronic sleep 
disturbances whereas 33% of women without diabetes and 42% of women with diabetes reported 
chronic sleep disturbances. While it is possible that the lower rate of chronic sleep disturbances 
in men is due to underreporting, we would not expect underreporting to be differential with 
respect to dietary intake.  
The aMedDiet score is based on population-specific intake of key dietary components 
representing the Mediterranean diet. Median values are gender-specific as they are based on 
daily servings and daily caloric intake is typically significantly higher in men than women. The 
aMedDiet was previously calculated for participants of the Nurses’ Health Study (NHS) to 
determine whether differences existed between healthy agers and usual agers (those who 
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developed chronic conditions. The NHS study population was free of chronic diseases and 
ranged in age from late 50s to early 60s (4). Our study population consumed approximately 150 
calories per day more than the usual agers and 200 calories more than healthy agers in the NHS. 
The average aMedDiet score among women in our study population was 4.0 compared to 4.5 in 
healthy agers and 4.3 in usual agers in the NHS study. The aMedDiet was used by DeKoning and 
colleagues to determine the risk of developing diabetes among participants in the Health 
Professionals Follow-Up Study (HPFS). Participants who were free of cardiovascular disease, 
type 2 diabetes and cancer were included. Participants in the lowest quartile of aMedDiet in the 
HPFS consumed on average 50 kcal more per day than our study population in the lowest 
quartile yet approximately 150 kcal less per day in highest quartile. On average, the BMI of men 
in the highest quartile in the HPFS was within normal range whereas the men in our study had a 
BMI indicative of obesity. The somewhat less healthy dietary profile in our study population 
compared to NHS and HPHS participants could be due to the differences in study populations. 
Our population is representative of the U.S. population whereas NHS and HPFS is a study of 
health professionals, free of chronic diseases, who may have been more informed of healthy 
dietary choices than the general population. Another explanation is the time difference in 
assessing diet between our study and the other two. Over the last thirty years, vast changes in the 
U.S. dietary pattern and food supply have occurred as well as dramatic increases in obesity rates. 
Both men and women in our study population had a less healthy dietary profile than participants 
in the NHS and HPFS.   
A strength of this study is the large, nationally representative sample that allow for 
analysis stratified by gender as well as comparisons of minority racial and ethnic subgroups. 
Limitations include the observational nature of the study which does not support causal 
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inference, despite the associations detected. Additionally, the exposure and the outcome 
variables are based on self-report and limited to those who provided the information, both of 
which could lead to potential sources of measurement error. Another limitation is the gender-
specific creation of the scores based on median intake within gender leading to composite scores 
which are not entirely comparable. However, including caloric intake in the regression analyses 
adjusts for variation due to higher daily consumption. Another limitation of the study is the lack 
of information on sleep apnea thus not allowing for the determination of the degree to which 
sleep disturbances are actually due to sleep apnea. 
Dietary intake is a modifiable risk factor that can reduce the impact of diabetes on the 
development of additional cardiovascular diseases. Evidence that sleep disturbances among 
individuals with diabetes reduces diet quality is important to take into account for both 
prevention and treatment purposes. Two primary areas of focus are to be highlighted with these 
findings: the need to ensure that those with diabetes continue to consume a healthy diet if they 
are already doing so, and the need to focus on chronic sleep disturbances as a potential source of 
reducing dietary quality in those with diabetes. Given the global impact at the population and 
individual level of increasing rates of diabetes, adding a piece of fruit, an extra serving of 
vegetables, a handful of nuts, or a splash of olive oil to one’s daily diet is a viable option to 
improving dietary consumption among adults with diabetes. However, economic barriers may 
reduce the current ability for older adults to adopt this behavior change and consume a 
Mediterranean-style diet. Providing low cost, affordable access to healthy foods is a key area for 
intervention. Additionally, the impact of chronic sleep disturbances should not be ignored in the 
on-going health and maintenance of those with chronic conditions such as diabetes. Chronic 
sleep disturbances should be assessed among older patients with diabetes by both clinicians as 
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well as nutritionists. Future studies are needed to confirm this relationship as well as to 
determine whether the glycemic control is reduced among those with diabetes and chronic sleep 
disturbances compared to those without chronic sleep disturbances. 
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Figure 4.1a Average aMedDiet Score Based on Comorbidity of Chronic Sleep Disturbances and Diabetes, by 
Gender, utilizing the gender-specific median values for the aMedDiet score. 
 
 
Differences within men: p<0.05; Differences within women, p<0.001; Differences between men and women p<0.05. 
aMedDiet: alternate Mediterranean Diet score, range from 0 to 9 based on median intake of 9 dietary components. 
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Figure 4.2b Average aMedDiet Score Based on Comorbidity of Chronic Sleep Disturbances and Diabetes, by 
Gender, utilizing the full sample median values for the aMedDiet score. 
 
 
 
Differences within men: p<0.05; Differences within women, p<0.001; Differences between men and women p<0.05. 
aMedDiet: alternate Mediterranean Diet score, range from 0 to 9 based on median intake of 9 dietary components. 
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  Men (n=2994) 
  
No sleep 
disturbances, no 
diabetes 
Sleep 
disturbances, 
no diabetes 
Diabetes, no 
sleep 
disturbances 
Diabetes AND 
sleep 
disturbances 
 
n=1527 (51.0%) n=668 (22.3%) n=530 (17.7%) n=269 (9.0%) 
aMedDiet Dietary Intake Components N (%) N (%) N (%) N (%) 
   Fruit, servings per day  753 (49.3) 330 (49.4) 292 (55.1) 127 (47.2) 
   Vegetables, servings per day 744 (48.7) 336 (50.3) 280 (52.8) 137 (50.9) 
   Whole grain, servings per day* 730 (47.8) 316 (47.3) 293 (55.3) 142 (52.8) 
   Red/processed meats, servings per day** 802 (52.5) 305 (45.7) 267 (50.4) 124 (46.1) 
   Alcohol, 1-2 drinks per day* 574 (37.6) 244 (36.5) 124 (23.4) 58 (21.6) 
   Nuts, servings per day 756 (49.5) 323 (48.4) 292 (55.1) 135 (50.2) 
   Legumes, servings per day 500 (32.7) 214 (32.0) 180 (34.0) 91 (33.8) 
   Fish, servings per day 724 (47.4) 311 (46.6) 255 (48.1) 119 (44.2) 
   MUFA:SFA ratio* 747 (48.9) 319 (47.8)     303 (57.2) 119 (44.2) 
  Women (n=4429) 
  
No sleep 
disturbances, no 
diabetes 
Sleep 
disturbances, 
no diabetes 
Diabetes, no 
sleep 
disturbances 
Diabetes AND 
sleep 
disturbances 
 
n=2253 (50.9%) n=1107 (25.0%) n=617 (13.9%) n=452 (10.2%) 
aMedDiet Dietary Intake Components N (%) N (%) N (%) N (%) 
   Fruit, servings per day**  1128 (50.1) 548 (49.5) 333 (54.0) 204 (45.1) 
   Vegetables, servings per day* 1179 (52.3) 530 (47.9) 316 (51.2) 195 (43.1) 
   Whole grain, servings per day** 1141 (50.6) 531 (48.0) 344 (55.8) 235 (52.0) 
   Red/processed meats, servings per day* 1151 (51.1) 521 (47.1) 292 (47.3) 199 (44.0) 
   Alcohol, 1-2 drinks per day* 545 (24.2) 262 (23.7) 59 (9.6) 48 (10.6) 
   Nuts, servings per day* 1155 (51.3) 533 (48.1) 273 (44.2) 210 (46.5) 
   Legumes, servings per day 772 (34.3) 337 (30.4) 209 (33.9) 134 (29.6) 
   Fish, servings per day 1081 (48.0) 511 (46.2) 287 (46.5) 226 (50.0) 
   MUFA:SFA ratio** 1172 (52.0) 518 (46.8) 327 (53.0) 221 (48.9) 
*p≤0.01; **p≤0.05 All percentages are weighted and standard errors account for the complex sample design. 
  
Table 4.1 Percent of the study population that consume above the median value of the aMedDiet dietary 
components by gender and comorbidity status.* 
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 Men (n=2994) Women (n=4429) 
 Quartile 1 Quartile 4 Quartile 1 Quartile 4 
 n=1288 n=718 n=1213 n=1030 
Demographic Characteristics # (%)  # (%)  # (%)  # (%)  
Age (mean yrs, SD) 65.1 (10.5) 64.5 (10.2) 64.5 (11.2) 64.1 (11.2) 
Race/Ethnicity* +     
   White/other, non-Hisp 973 (75.5) 520 (72.4) 891 (73.5) 702 (68.2) 
   Black, non-Hisp 180 (14.0) 81 (11.3) 227 (18.7) 163 (15.8) 
   Hispanic 135 (10.5) 117 (16.3) 95 (7.8) 165 (16.0) 
Education*+     
   <High school 301 (23.4) 128 (17.8) 288 (23.7) 163 (15.8) 
   High school 653 (50.7) 273 (38.0) 676 (55.7) 462 (44.9) 
   Some college 78 (6.1) 36 (5.0) 86 (7.1) 84 (8.2) 
   College/Professional degree 256 (19.9) 281 (39.1) 163 (13.4) 321 (31.2) 
Currently married+ 959 (74.5) 547 (76.2) 634 (52.3) 628 (61.0) 
Currently working* 514 (39.9) 340 (47.4) 461 (38.0) 425 (41.3) 
Health Behaviors     
   Weekly moderate or vigorous phys activity*+ 864 (67.1) 582 (81.1) 643 (53.0) 773 (75.0) 
   Current smoker*+ 249 (19.3) 58 (8.1) 227 (18.7) 72 (7.0) 
Health Conditions     
   Diabetes++ 325 (25.2) 194 (27.0) 296 (24.4) 209 (20.3) 
   Hypertension+ 760 (59.0) 395 (55.0) 717 (59.1) 499 (48.4) 
   Heart disease+ 339 (26.3) 162 (22.6) 257 (21.2) 148 (14.4) 
   Heart attack++ 131 (10.2) 58 (8.1) 55 (4.5) 27 (2.6) 
   Depression** + 185 (14.4) 76 (10.6) 313 (25.8) 194 (18.8) 
   BMI (mean, SD)+ 30.4 (5.4) 30.3 (5.2) 31.3 (7.3) 29.3 (6.2) 
      Normal weight+ 175 (13.6) 83 (11.6) 226 (18.6) 259 (25.1) 
      Overweight 499 (38.7) 300 (41.8) 343 (28.3) 347 (33.7) 
      Obese 614 (47.7) 335 (46.7) 644 (53.1) 424 (41.2) 
Chronic sleep disturbances     
 Trouble falling asleep, most of the time*+ 161 (12.5) 49 (6.8) 222 (18.3) 118 (11.5) 
 Trouble waking up at night, most of the time++ 317 (24.6) 160 (22.3) 326 (26.9) 224 (21.7) 
 Trouble waking up too early++ 174 (13.5) 85 (11.8) 178 (14.7) 110 10.7) 
 One or more chronic sleep disturbance*+ 430 (33.4) 209 (29.1) 461 (38.0) 309 (30.0) 
Comorbidity of diabetes and chronic sleep 
disturbances** ++     
   No diabetes diagnosis/no chronic sleep disturbance 660 (51.2) 367 (51.1) 592 (48.8) 585  (56.8) 
   Chronic sleep disturbances, no diabetes 303 (23.5) 157 (21.9) 325 (26.8) 236 (22.9) 
   Diabetes, no chronic sleep disturbances 198 (15.4) 142 (19.8) 160 (13.2) 136 (13.2) 
   Diabetes and chronic sleep disturbances 127 (9.9) 52 (7.2) 136 (11.2) 73 (7.1) 
Nutritional values     
Total Calories per day (mean, SD)* + 1716 (703) 2436 (1013) 1422 (582) 2258 (874) 
Alternate Mediterranean diet score (mean, SD)* + 2.2 (0.9) 6.7 (0.8) 1.5 (0.7) 6.7 (0.8) 
*p<0.001 men, +p<0.001 women; **p<0.05 men, ++p<0.05 women    
Table 4.2 Sample characteristics for quartiles 1 and 4 (lowest and highest) of aMedDiet score, by gender. 
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Table 4.3 Odds ratio of consuming a healthy diet due to comorbidity of diabetes and chronic sleep disturbances, by 
gender. 
 
Men 
Adjusted for age 
and caloric intake 
Adjusted for 
additional 
covariates* 
No diabetes, no sleep disturbances REF REF  
Sleep disturbances, no diabetes 0.86 (0.67-1.11) 1.02 (0.78-1.34)  
Diabetes, no sleep disturbances 1.45 (1.11-1.91) 1.70 (1.25-2.29)  
Both diabetes and sleep disturbances 0.73 (0.50-1.07) 1.03 (0.67-1.56)  
    
Women 
Adjusted for age 
and caloric intake 
Adjusted for 
additional 
covariates*  
No diabetes, no sleep disturbances REF REF  
Sleep disturbances, no diabetes 0.71 (0.56-0.90) 0.87 (0.67-1.12)  
Diabetes, no sleep disturbances 0.83 (0.62-1.12) 1.15 (0.82-1.62)  
Both diabetes and sleep disturbances 0.53 (0.37-0.77) 0.81 (0.54-1.22)  
 
Data are OR (95% CI).  Odds of being in the highest quartile of the gender-specific Mediterranean Diet score vs  
the lowest quartile. 
REF: Reference group in all models are those without chronic sleep disturbances or diabetes. 
*Multivariate models are adjusted for age, daily caloric intake, race/ethnicity, education, employment status, marital status, 
hypertension, depression, smoking, physical activity and obesity 
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Table 4.4 Multivariate linear regression assessing the association between diabetes and chronic sleep  
disturbances and the aMedDiet score. 
 
Full Study Population Estimate (95% CI) 
 
 
p 
No diabetes, no sleep disturbances REF  
Sleep disturbances, no diabetes 0.03 (-0.13-0.20) 0.70 
Diabetes, no sleep disturbances 0.22 (0.06-0.37) 0.01 
Both diabetes and sleep disturbances -0.14 (-0.25- -0.03) 0.02 
 
REF: Reference group in all models are those without chronic sleep disturbances or diabetes. 
*Multivariate models are adjusted for age, gender, daily caloric intake, race/ethnicity, education, employment status, marital status, h  
depression, smoking, physical activity and obesity 
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 Men Women All 
 n= 2994 n= 4429 n=7423  
Demographic Characteristics # (%)  # (%)  # (%)  
Age (mean yrs, SD) 65.2 (10.5) 64.9 (11.4) 65.0 (11.0) 
Race/Ethnicity*    
   White/other, non-Hisp 2225 (74.3) 3145 (71.0) 5370 (72.3) 
   Black, non-Hisp 405 (13.5) 777 (17.5) 1182 (15.9) 
   Hispanic 364 (12.2) 507 (11.4) 871 (11.7) 
Education*  13.5 (3.0) 12.9 (2.8) 13.1 (2.9) 
   <High school 618 (20.6) 892 (20.1) 1510 (20.3) 
   High school 1364 (45.6) 2260 (51.0) 3624 (48.8) 
   Some college 172 (5.7) 314 (7.1) 486 (6.5) 
   College/Professional degree 840 (28.1) 963 (21.7) 1803 (24.3) 
Currently married* 2254 (75.3) 2469 (55.7) 4723 (63.6) 
Currently working* 1262 (42.2) 1675 (37.8) 2937 (39.6)     
Health Behaviors    
   Weekly moderate or vigorous phys activity* 2174 (72.6) 2803 (63.3) 4977 (67.0) 
   Current smoker** 443 (14.8) 571 (12.9) 1014 (13.7) 
   Alcohol use >= 2d/wk* 1000 (33.4) 914 (20.6) 1914 (25.8)     
Health Conditions    
   Diabetes** 799 (26.7) 1069 (24.1) 1868 (25.2) 
   Hypertension 1714 (57.2) 2479 (56.0) 4193 (56.5) 
   Heart disease* 741 (24.7) 804 (18.2) 1545 (20.8) 
   Heart attack* 280 (9.4) 182 (4.1) 462 (6.2) 
   Depression* 358 (12.0) 993 (22.4) 1351 (18.2) 
   BMI (mean, SD)* 917 (46.7) 1349 (48.2) 2266 (47.6) 
   Normal weight 369 (12.3) 928 (21.0) 1297 (17.5) 
   Overweight 1211 (40.4) 1363 (30.8) 2574 (34.7) 
   Obese 1414 (47.2) 2138 (48.3) 3552 (47.9)     
Chronic sleep disturbances    
 Trouble falling asleep, most of the time* 293 (9.8) 712 (16.1) 1005 (13.5) 
 Trouble waking up at night, most of the time* 709 (23.7) 1102 (24.9) 1811 (24.4) 
 Trouble waking up too early* 358 (12.0) 601 (13.6) 959 (12.9) 
 One or more chronic sleep disturbance* 937 (31.3) 1559 (35.2) 2496 (33.6)     
Comorbidity of diabetes and chronic sleep disturbances*   
   No diabetes diagnosis/no chronic sleep disturbance 1527 (51.0) 2253 (50.9) 3780 (50.9) 
   Chronic sleep disturbances, no diabetes 668 (22.3) 1107 (25.0) 1775 (23.9) 
   Diabetes, no chronic sleep disturbances 530 (17.7) 617 (13.9) 1147 (15.5) 
   Diabetes and chronic sleep disturbances 269 (9.0) 452 (10.2) 721 (9.7)     
Nutritional values    
Total Calories per day (mean, SD)* 2013 (890) 1797 (812) 1884 (851) 
Alternate Mediterranean diet score (0-9) (mean, SD) 4.0 (2.0) 3.9 (2.0) 4.0 (2.1) 
*p<0.001,**p<0.05    
 
  
Table 4.S1 Baseline characteristics of the study population. 
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 Criteria for Maximum Score (1)    
Component Men Women Full Sample    
Fruit (a), servings/day >1.7 >1.8 >1.6     
Vegetables (b), servings/day >2.3 >2.5 >2.3     
Whole grains (c), servings/day >0.6 >0.6 >0.6     
Red/processed meats (d), servings/day <0.7 <0.5 >0.6     
Alcohol (e), servings/day >.5, <=2 >.5, <=1.5 >.5, <=2     
Nuts (f), servings/day >0.4 >0.3 >0.4     
Legumes (g), servings/day >0.1 >.1 >0.1     
Fish (h), servings/day >.2 >.2 >0.1     
MUFA/SFA >1.1 >1.0 >0.2     
Abbreviations: MUFA: monounsaturated fats; SFA: saturated fats.      
The cut-offs were based on the median intake values by gender, as well as for the full sample, from the original population,  
with the exception of alcohol. For alcohol, 1 point was given for moderate intake, 0 points were given for no  
alcohol or heavy alcohol consumption. For red/processed meats, 1 point was given for consumption  
below the median. Apart from alcohol and red/processed meats, 1 point is given for values above  
the gender-specific median value. 
 
aIncludes whole fruit and fruit juice. One serving is 1 medium piece of fruit or 0.5 cup of berries or a small  
glass of fruit juice. 
bIncludes all vegetables except potatoes. One serving is 0.5 cup of vegetables or 1 cup of green leafy  
vegetables.  
cOne serving is 1 cup of cooked oatmeal, brown rice or other grain (bulghur, kasha, buckwheat) or  
1 slide of dark or wheat bread. 
dOne serving is 4 oz of unprocessed meat or 1.5 oz of processed meat.      
eOne serving is one bottle of beer, a 5 oz glass of  wine, or 1 drink or shot of liquor     
fOne serving is 1 oz of nuts or 1 tablespoon of peanut butter      
gOne serving is 0.5 cup         
hOne serving is 2-5oz.         
 
Table 4.S2 The Alternate Mediterranean diet scoring system in the Health and Retirement Study. 
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Chapter 5  Discussion 
Summary & implications of main findings 
Our research provides new evidence on the multi-directional association between chronic 
sleep conditions and chronic diseases. We live in an aging society. It is estimated that between 
2012 and 2035 the percentage of the U.S. population aged 65 and older will increase from 14% 
to 22% representing an increase of over 20 million individuals in this age range (1). Given the 
increased health care costs among older adults, an emphasis should be placed on healthy aging. 
Over 60% of adults aged 65 and older have at least one chronic condition. Twenty-five percent 
have 3 or more chronic conditions (2). Comorbidity of chronic conditions leads to extensive 
health care costs at the individual as well as societal levels. Our research has provided further 
support that chronic sleep disturbances are associated with new chronic conditions, type II 
diabetes specifically, and may also be considered a comorbid health condition among those with 
existing diabetes as it leads to impaired glucose tolerance and insulin sensitivity (shown 
previously) and leads to disturbances in healthy eating which is critical for those with diabetes.  
Several over-arching novelties exist in this research including: 
- The focus on sleep quality rather than sleep duration as it relates to chronic conditions. Sleep 
quality may be easier for individuals to assess compared to sleep duration as it is a subjective 
measure, to some degree. When relying on self-reported measures, sleep duration is often mis-
reported as we do not know exactly what time we fall asleep nor the exact duration of time spent 
awake at night. Previous studies have demonstrated a U-shaped relationship between sleep 
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duration and mortality, cancer and cardiovascular disease. Those who sleep less than six hours a 
night or more than ten hours are at increased risk of mortality and development of chronic 
diseases compared to those who sleep seven to eight hours a night. Although results have varied, 
previous studies have found that men with increased sleep duration appear to have the greatest 
risk of mortality and developing chronic conditions. Women tend to report higher levels of short 
and long-term sleep disturbances. However, fewer studies have assessed the association between 
sleep disturbances, or poor sleep quality, and the development and progression of disease. Sleep 
duration does not inform us of sleep quality, or where in the sleep cycle disturbances may have 
occurred. Disruptions in sleep quality may be better predictors of disease risk than sleep duration 
as sleep duration can be misclassified as “normal” duration if, for example, individuals with poor 
quality sleep due to sleep disruptions tend to stay in bed longer to attempt to make up the lost 
sleep. Additionally, some precision may be lost when asking participants in population-based 
studies to report sleep duration. This lack of precision could lead to measurement error in the 
form of over or under-reporting sleep duration. Sleep quality may be easier to assess. Self-
reported sleep quality is assessed with questions on difficulty falling asleep and difficulty staying 
asleep. These qualitative measures may be easier to report accurately than the quantitative 
measure of duration. Studies utilizing actigraphy or wearable fitness monitors have found a good 
correlation between self-reported measures of sleep quality and sleep disturbances measured via 
actigraphy. 
- The analyses were stratified by gender, thereby allowing for the assessment of variation 
in the associations between other covariates of interest and known confounders, which may vary 
by gender as well as the relationship between chronic sleep disturbances and type II diabetes. 
The large sample size of the Health and Retirement Study allowed for stratification by gender to 
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assess these associations, several of which had not been reported previously. Additionally, we 
were able to quantify the difference in risk for women versus men for the various associations 
between chronic sleep disturbances and diabetes. This research highlights the importance of 
sleep quality, especially among women. Poor quality or inadequate sleep can be considered a life 
course issue as it affects individuals at various points over the course of life (newborns, 
teenagers, young adults, during menopause, older adults). It may be that the cumulative burden 
of poor quality sleep over the life course is greater for women. While other studies will be able to 
address sleep disturbances at critical times, we are able to show that the multi-directional 
association between chronic sleep disturbances and diabetes is greater in women than men in 
each of our three papers. 
- Also due to the large sample size, as well as the oversample of Black and Hispanic 
minority populations in the Health and Retirement Study, our research is able to provide new and 
additional information regarding chronic sleep disturbances and the association with a chronic 
condition among a multi-ethnic population of older adults. While previous studies have assessed 
differences in sleep quality by race and ethnicity, longitudinal studies of these associations and 
how they vary by race/ethnicity within gender have not been reported.  
- The assessment of chronic conditions as potential confounders and/or mediators in the 
relationship between chronic sleep disturbances and type II diabetes in our research has shown 
that individuals with comorbidity of multiple chronic conditions are more likely to develop 
chronic sleep disturbances. When we consider chronic sleep disturbances as a comorbid 
condition in the presence of type II diabetes, we observe an antagonist effect between the 
conditions which leads to poor dietary intake. 
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Novel Findings 
Aim 1: Previous longitudinal studies assessing the association between chronic sleep 
disturbances and incident diabetes focused primarily on sleep duration, rather than sleep quality 
(3, 4). Most of these studies were unable to report differences by gender. Data reported from the 
United States on the association between chronic sleep disturbances and incident diabetes has 
primarily been cross-sectional in nature (5-7). To our knowledge, this is the first population-
based study from the U.S. to report a longitudinal association between chronic sleep disturbances 
and incident diabetes as well as to provide information by gender and race/ethnicity. As our 
society shifts to individualized medicine, a better understanding of individual level risk factors is 
important in the prevention, detection and treatment of disease. In our study, we found that 
women suffer from chronic sleep disturbances at a higher rate than men and have a greater 
likelihood of developing type II diabetes in the presence of chronic sleep disturbances.  
Aim 2: While previous studies have assessed chronic sleep disturbances as an antecedent 
of type II diabetes as well as the prevalence of chronic sleep disturbances among those with 
diabetes, population-based studies have not assessed the development of new chronic sleep 
disturbances after diagnosis of type II diabetes. Given the negative effects of chronic sleep 
disturbances on glycemic regulation and inflammation, the new development of chronic sleep 
disturbances may play an important role in the development and progression of chronic 
conditions as a result of uncontrolled diabetes (Trento 2008, 4). Our study detected an increased 
association of developing new chronic sleep disturbances within four years of diagnosis of 
diabetes in women, but not in than men.  
Aim 3: Our study found an antagonistic association of chronic sleep disturbances among 
those with type II diabetes leading to lower intake of a healthy diet. To our knowledge, this is the 
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first study to assess the joint associations of chronic sleep disturbances and chronic conditions on 
dietary intake. One of the first areas of intervention among those newly diagnosed with diabetes 
is regarding dietary intake as the composition of one’s diet is key in maintaining glycemic 
control among those with type II diabetes (American Diabetes Association, 2016). The 
Mediterranean diet has previously been found to be both protective against the development of 
type II diabetes as well as a healthy diet among those with type II diabetes. We found that men 
with type II diabetes are more likely to consume a healthier diet, such as a Mediterranean-style 
diet, unless they are also experiencing chronic sleep disturbances. However, it does not appear 
that older adult women with type II diabetes consume a healthy diet and the odds of doing so are 
even lower in the presence of chronic sleep conditions. 
Gender and Chronic Sleep Disturbances 
In each of the three primary aims, differences in associations were detected for men and 
women. Women appear to suffer from chronic sleep disturbances to a greater degree than men 
and the association between chronic sleep disturbances and incident diabetes appears to be 
greater in women than men. Additionally, chronic sleep disturbances among women with 
diabetes appears to have a negative association with healthy dietary intake. There are several 
potential reasons for the gender-based differences detected in our research. First, it is possible 
that men underreport chronic sleep disturbances when self-reported measures are used. Next, as 
women age and experience hormonal changes related to menopause, an increase in chronic sleep 
disturbances may occur. While the majority of our study population had likely completed their 
menopausal transition at the time of participation, unresolved disruptions in circadian rhythms or 
sleep disturbances may have still existed. Women report higher rates of other chronic conditions, 
such as pain, incontinence and depression and anxiety which are also associated with sleep 
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disturbances. Medications taken for these same conditions may also lead to increased nocturnal 
as well as sleep disruptions. Additionally, women may be more susceptible to other 
environmental factors or psychosocial stressors that are associated with chronic sleep 
disturbances. Future research in the field of genetics will help us better understand the potential 
genetic differences in chronic sleep disturbances among men and women, as well as the 
proportion of disturbances attributable to genetics versus other environmental or emotional and 
physical health factors. 
Strengths 
This research has several strengths. The data utilized to assess these three areas of 
research are representative of the U.S. population over the age of 50 thus allowing for the 
generalizability of the results to the broader U.S. population. Additionally, the high response 
rates achieved by the Health and Retirement Study as well as the panel retention rates decrease 
the potential for non-response bias due to loss to follow-up. The bi-annual response rates often 
approach 90% and the response rate for the Health Care and Nutrition Mail Survey, utilized in 
aim 3, was close to 70%. The large sample size and inclusion of a minority oversample allows 
for the detection of associations by gender and race/ethnicity. Additionally, the analysis of blood 
spot samples among a random half of the study population every two years allowed for the 
detection of approximately thirty-percent more cases of diabetes than by self-report alone. It is 
estimated that 25% of those with type 2 diabetes in the U.S. are not diagnosed.  
Limitations 
The primary limitation of this research is the reliance on self-reported measures of type II 
diabetes and chronic sleep disturbances. Self-reported measures are subject to measurement 
errors such as recall bias, over- or under-reporting, potentially due to social desirability. It is 
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possible that self-reported sleep disturbances among men were under-reported, as other studies 
have found (American Community Survey). The inability to clinically validate either of these 
measures, type II diabetes and chronic sleep disturbances, is a limitation. However, the incidence 
and prevalence rates of both type II diabetes and chronic sleep disturbances are similar to those 
previously reported which is reassuring. The frequency of the measurements is a limitation as 
well. Chronic sleep disturbances were assessed every four years and incident diabetes is assessed 
every two years. Thus, the precision of the dates in which these conditions first appeared is 
unknown and changes in conditions between interview dates is not known either. Finally, we 
cannot determine the impact of unmeasured confounders in the associations we have detected. At 
this time, information on family history of disease or the presence of other health conditions 
related to chronic sleep disturbances, such as sleep apnea and restless leg syndrome, is not 
available for our study population. 
Towards public health and policy 
Sleep is a basic biological need (3). Sleep is also a modifiable risk factor. While many 
interventions target increased physical activity and a healthy diet, few have targeted healthy 
sleep conditions. However, several public health campaigns have focused on sleep conditions 
among subgroups of populations. This has included the “Back to Sleep” campaign to reduce the 
risk of sudden infant death syndrome (SIDS) in newborns as well as recent legislation to shift the 
start time of high school classes given new knowledge of the circadian rhythms of adolescents 
and the decreased sleep that potentially leads to negative mental and physical health 
consequences. Professional associations, such as those regulating airplane pilots or truck drivers, 
have also begun to provide restrictions on shift durations given the increased rates of accidents 
and other health-related risks due to prolonged lack of sleep. While the National Sleep 
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Foundation has recently promoted a “national sleep awareness week”, additional focus should be 
placed on providing information to the public regarding the need for quality sleep. Previously, 
the focus has primarily been on sleep duration. However, sleep duration varies by age and by 
individual. Some individuals function well with six hours of sleep on a regular basis while others 
need a full eight hours. Additionally, it is not only sleep duration, but also sleep quality that 
increases the risk for the development and progression of other chronic conditions, as we have 
shown. Our study and others have shown that waking up at night and being unable to fall back 
asleep is the most frequent sleep disruption and may also be the most harmful in terms of 
increasing risk for other chronic conditions. Our current society seems to reinforce disrupted 
sleep given the ability, and expectation in some circumstances, to be connected and engaged 
around the clock. Public awareness of the deleterious effects of disrupted sleep must be 
increased. Additionally, greater awareness of sleep hygiene techniques that are useful to help one 
return to sleep must be increased. While prevention is necessary, early detection of chronic sleep 
disturbances is key as well. Physicians and clinicians must begin to incorporate an assessment of 
sleep disturbances into their clinical practice in order to detect early stages of chronic sleep 
disturbances, which is when interventions are most successful. The rapid increase in the use of 
over-the-counter sleep aides is indicative of the increased rate of sleep disturbances and, 
potentially, the lack of discussion of other useful techniques in improving sleeping conditions 
and sleep quality.  
Future directions 
Further studies of disruptions of sleep over the life course and the impact on longer term 
development and progression of chronic conditions is necessary. While we have provided 
additional, and new, evidence of the deleterious and multi-directional effects of poor sleep 
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quality and type II diabetes, the association with other chronic conditions related to inflammation 
should be assessed as well. Additionally, we must continue to explore these relationships taking 
into account the potential for variation due to gender and race/ethnicity, some of which is due to 
society and environmental conditions as well as potential genetic differences. The field of 
genetic research is expanding our knowledge of the predisposition for certain health conditions. 
Recent studies have detected genetic predisposition for chronic sleep disturbances which will 
improve our ability to provide individualized recommendations in the prevention and treatment 
of sleep disturbances. Additionally, the development of sensors and wearables, such as Fitbits, 
allow for both increased individual awareness of one’s sleep patterns as well as provide a new 
means of objectively measuring both sleep duration and sleep quality. As these devices become 
more prominent, both in the U.S. and internationally, costs will decrease and data sharing will 
become more prevalent, thus facilitating use in population-based research.  
Conclusion 
The focus on the effects of sleep disturbances on health, in terms of the epidemiology and 
physiology, is recent. As an example, a PubMed search on the terms “diabetes” and “sleep 
quality”, “sleep disruptions” or “sleep disturbances” yielded 2 citations between 1980-1989, 13 
citations between 1990-1999, 90 citations between 2000-2009, and 453 citations between 2010-
2017 with close to 60% of those published in the last two years (between 2015-2017)  
(www.ncbi.nlm.nih.gov/pubmed, doi 11-25-2017). The first textbook on sleep epidemiology, 
Sleep, health and society: from aeitology to public health, was published in 2010. In the 
foreward, Professor Sir Michael Marmot ponders “Is sleep a cause, a symptom or a 
consequence?” Lead editor Francesco Cappuccio reiterates this question as it relates to various 
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health conditions throughout the book. This dissertation attempts to help address this question, as 
it relates to diabetes.  
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